B Cell Receptor Signaling Pathway%WikiPathways_20191210%WP23%Homo sapiens -7.07 -3.39 -5.19 -11.54 4.45 5.9 3.25 0.54 2.58 3.18 -3.29 2.75 4.08 4.35 4.12 -0.31 -2.86 -5.04 2.36 3.11 -5.74 -1.4 2.86 6.58 -0.39 -3.88
Trans-sulfuration pathway%WikiPathways_20191210%WP2333%Homo sapiens 3.87 3.05 -4.8 -3.43 2.91 0.91 -1.04 -0.83 -0.85 -0.46 -0.32 1.11 -0.41 -0.57 -0.6 -0.44 1.56 1.97 1.46 -0.84 1.07 0.35 -1.68 -2.77 -0.21 0.98
Nanoparticle triggered autophagic cell death%WikiPathways_20191210%WP2509%Homo sapiens 1.51 -0.54 5.55 6.08 1.09 0.04 -0.07 -2.17 2.05 0.58 3.83 -2.01 -0.39 0.42 -2.79 1.37 -1.06 -1.36 0.83 -1.89 -2.77 -2.61 0.25 -1.44 -2.29 -2.22
Mammary gland development pathway - Embryonic development (Stage 1 of 4)%WikiPathways_20191210%WP2813%Homo sapiens -1.68 -2.06 -2.65 -5.91 2.92 2.07 1.43 0.44 1.41 1.39 -2.07 0.74 1.2 0.57 -0.56 -0.7 0.65 -2.14 -0.46 -0.17 -0.8 -0.9 3.28 3.88 0.3 -0.19
Calcium Regulation in the Cardiac Cell%WikiPathways_20191210%WP536%Homo sapiens -4.27 -2.22 -7.37 -17.49 2.85 6.73 2.69 0.88 2.01 2.61 -5.05 2.17 4.18 6.27 1.92 1.76 -8 -3.22 4.72 6.43 -6.08 -1.88 4.38 9.47 0.26 -3.76
Alanine and aspartate metabolism%WikiPathways_20191210%WP106%Homo sapiens -3.9 -2.04 1.97 -3.02 -1.43 0.96 1.09 0.48 0.88 0.81 -1.9 0.35 0.07 1.5 1.25 1.21 -1.77 -1.09 -1.15 0.89 -1.3 -0.98 1.79 2.7 1.6 1.05
White fat cell differentiation%WikiPathways_20191210%WP4149%Homo sapiens 0.52 0.46 1.87 -0.47 -3.72 -4.05 -1.3 0.53 -2.66 -2.28 0.05 -1.36 -1.16 -2.52 1.99 -0.41 3.1 2.31 -2.46 -0.33 6.15 5.58 -2.41 -2.07 1.73 2.92
EGF/EGFR Signaling Pathway%WikiPathways_20191210%WP437%Homo sapiens -5.78 -5.82 -6.28 -10.97 7.93 8.75 3.02 -1.02 6.1 5.86 -3.68 3.87 4.37 5.24 0.42 -1.8 -2.4 -6.8 0.5 3.08 -10.03 -4.91 7.53 8.13 -1.03 -4.26
DNA Replication%WikiPathways_20191210%WP466%Homo sapiens -2.11 -3.09 -3.89 -9.55 3.56 4 1.27 -1.1 1.49 3.04 -1.53 0.75 3.16 4.19 1.71 1.59 -1.55 -1.33 0.92 0.25 -3.93 0.31 2.56 1.64 -0.6 -1.77
Pyrimidine metabolism%WikiPathways_20191210%WP4022%Homo sapiens 6.43 3.83 -9.99 -12.02 5.46 4.88 0.2 -1.69 1.04 0.45 -3.34 0.81 3.15 2.81 -0.83 -2.71 0.61 2.37 4.85 2.21 -1.13 -3.36 -0.11 -1.51 -0.69 -1.72
Vitamin B12 Metabolism%WikiPathways_20191210%WP1533%Homo sapiens -5.78 -5.25 -1.09 -5.45 3.73 5.94 0.34 -0.05 1.72 3.05 -2.59 0.27 4.13 3.37 0.52 1.36 -2.31 -6.49 -1.23 1.13 -4.78 0.02 3.31 3.96 1.71 0.47
Angiopoietin Like Protein 8 Regulatory Pathway%WikiPathways_20191210%WP3915%Homo sapiens 6.61 3.04 5.81 10.6 -5.76 -7.43 -1.16 1.86 -4.5 -4.14 3.13 -2.75 -4.64 -6.11 -1.53 -1.22 3.07 4.97 -3.56 -1.77 9.86 4.14 -6.1 -8.06 1.08 4.55
DNA Damage Response%WikiPathways_20191210%WP707%Homo sapiens 4.73 4.47 5 9.06 -4 -6.01 -1.9 1.02 -3.12 -4.39 3.66 -1.71 -4.67 -4.55 -0.87 0.54 3.34 4.67 -1.34 -2.42 6.43 2.38 -5.38 -5.74 -0.95 1.76
Oxidative Damage%WikiPathways_20191210%WP3941%Homo sapiens -4.77 -3.42 -1.22 -2.74 -0.38 1.37 2.64 1.81 1.45 3.45 -0.15 2.35 1.09 2.78 3.72 1.1 -2.17 -1.4 1.76 1.57 -3.75 -2.47 3.02 3.89 -3.28 -6.25
Spinal Cord Injury%WikiPathways_20191210%WP2431%Homo sapiens 8.03 4.53 4.54 9.66 -4.53 -7.79 -3.43 -0.35 -3.14 -3.88 1.23 -1.43 -5.09 -4.68 -2.52 -1.89 4.95 5.62 -1.63 -3.91 9.17 3.51 -3.47 -7.43 0.52 3.41
Nicotine Activity on Dopaminergic Neurons%WikiPathways_20191210%WP1602%Homo sapiens -3.17 -3.22 1.92 1.68 -1.55 0.73 3.33 1.61 1.62 2.65 -1.79 -2.49 1.11 1.38 2.8 0.71 -2.79 -3.37 -0.61 2.58 -4.05 -0.78 0.89 1.04 0.81 -1.04
PI3K/AKT/mTOR - VitD3 Signalling%WikiPathways_20191210%WP4141%Homo sapiens 3.01 1.91 2.47 5.99 -1.59 -3.3 -2.07 -0.21 -0.34 -1.81 3.41 -1.13 -1.7 -2.99 -1.38 -0.79 2.12 2.41 -1.9 -2.23 4.14 1.46 -1.91 -3.55 -0.86 0.83
IL-1 signaling pathway%WikiPathways_20191210%WP195%Homo sapiens -3.98 -3.45 -3.21 -5.58 3.39 4.94 1.95 -1.19 3.77 3.2 -1.36 1.04 2.73 2.75 2.3 1.43 -4 -3.17 1.57 0.58 -6.16 -2.94 3.54 4.79 -0.77 -2.16
Gastric Cancer Network 1%WikiPathways_20191210%WP2361%Homo sapiens -4.15 -2.66 -2.29 -7.16 2.7 3.45 1.93 1.12 0.13 3.39 -3.17 -0.47 3.15 3.84 1.54 1.78 -1.2 -3.42 0.27 -0.05 -2.48 0.3 1.62 1.7 0.22 -0.11
Copper homeostasis%WikiPathways_20191210%WP3286%Homo sapiens 0.27 1.33 -4.82 -7.12 5.34 5.35 2.04 -1.99 3.33 3.45 -3.55 1.19 2.87 2.93 -0.1 -1.78 -2.4 -3.79 2.46 1.91 -6.25 -5.37 4.39 4.98 -1.12 -3.55
Kit receptor signaling pathway%WikiPathways_20191210%WP304%Homo sapiens 3.24 1.55 6.82 12.57 -3.05 -4.39 -2.53 -0.84 -2.7 -1.8 3.77 -1.78 -3.12 -2.65 -1.35 -0.05 -0.26 2.09 -2.62 -1.74 3.11 1.29 -3.01 -3.94 -0.33 1.71
TGF-beta Receptor Signaling%WikiPathways_20191210%WP560%Homo sapiens 3.8 2.39 5.99 9.88 -2.24 -4.37 -2.35 -0.88 -0.88 -0.84 6.08 -0.82 -3.22 -2.85 1.19 0.39 -0.52 1.13 -1.4 -3.06 1.86 -0.71 -1.57 -4.64 -1.7 -0.63
Vitamin D Metabolism%WikiPathways_20191210%WP1531%Homo sapiens -3.29 -3.46 -0.69 -3.33 1.49 2.3 1.5 0.84 0.19 1.43 -2.24 0.32 1.52 1.69 -0.16 1.14 -0.02 -1.91 -1.92 0.2 -0.97 0.03 1.14 1.64 1.5 1.06
miRNAs involvement in the immune response in sepsis%WikiPathways_20191210%WP4329%Homo sapiens 3.59 4.45 2.25 3.89 -3.64 -4.66 -1.48 1.05 -1.33 -2.75 2.9 -0.8 -1.86 -2.09 -1.54 -0.39 3.59 4.31 -2.59 -1.82 3.7 1.14 -3.51 -4.8 0.35 2.04
Prostaglandin Synthesis and Regulation%WikiPathways_20191210%WP98%Homo sapiens 5.61 3.45 3.49 4.57 -2.68 -4.58 -2.24 -0.07 -2.15 -2.75 2.22 -1.35 -3.64 -3.26 -2 -1.98 3.72 5.06 2.6 -0.92 4.18 2.45 -3.3 -4.12 -1.6 -0.7
Amyotrophic lateral sclerosis (ALS)%WikiPathways_20191210%WP2447%Homo sapiens 2.08 1.73 3.62 6.48 -1.18 -2.95 -2.23 0.38 -2.88 -2.73 1.26 -0.38 -2.33 -3.34 -1.02 -1.06 4.34 4.15 -0.99 -0.35 3.39 1.83 -3.39 -4.44 -1.51 1.52
Serotonin Receptor 4/6/7 and NR3C Signaling%WikiPathways_20191210%WP734%Homo sapiens 1.49 1.43 -2.91 -4.18 -1.87 -2.5 -0.26 2.54 -2.79 -1.62 -1.78 -0.34 -0.17 -0.25 2.35 0.87 1.32 2.98 -0.16 0.22 3.99 2.89 -3.16 -2.91 1.76 3.08
ID signaling pathway%WikiPathways_20191210%WP53%Homo sapiens -2.95 -2.58 -1.7 -3.48 1.93 3.28 -0.65 0.9 -0.11 2.56 -2.56 -0.05 1.9 3.06 -1.4 -0.37 -0.03 -3.16 -0.96 2.11 -1.66 0.82 1.57 3.12 -0.21 0.63
Integrated Breast Cancer Pathway%WikiPathways_20191210%WP1984%Homo sapiens -5.39 -4.13 -7.07 -12.31 6.87 8.55 3.08 -1.65 3.96 5.04 -4.28 0.68 5.83 6.32 0.85 -0.24 -4.1 -6.41 1.76 1.99 -7.8 -3.35 6.19 7.7 0.51 -2.61
Glycerolipids and Glycerophospholipids%WikiPathways_20191210%WP4722%Homo sapiens -3.16 -1.83 3.04 5.47 -4.52 -2.24 0.59 0.7 -0.33 -1.71 -1.26 -0.96 0.42 -0.05 1.04 -0.89 -1.02 0.54 -2.9 1.19 2.78 1.65 -0.48 1.49 1.78 0.66
Type II interferon signaling (IFNG)%WikiPathways_20191210%WP619%Homo sapiens 5.49 5.02 1.05 4.43 -1.29 -3.12 0.15 0.46 -1.83 -2.7 1.71 0.38 -2.99 -2.34 -1.77 -1.67 4.45 6.22 0.47 -0.62 1.34 -2.41 -2.82 -4.44 -2.19 -0.96
Development and heterogeneity of the ILC family%WikiPathways_20191210%WP3893%Homo sapiens -7.78 -4.21 -0.16 -5.67 2.16 4.53 1.98 0.75 0.89 2.17 -3.43 -0.85 2.99 1.74 2.11 0.55 -2.59 -4.68 -0.94 1.48 -3.77 0.4 3.52 4.97 2.68 1.16
Mitochondrial LC-Fatty Acid Beta-Oxidation%WikiPathways_20191210%WP368%Homo sapiens 3.74 3.39 -5.94 -4.26 2.97 1.14 0.31 0.79 -0.2 0.33 -1.5 1.27 -1.08 -1.23 -0.35 -1.25 -0.09 2.36 2.98 1.49 0.67 -2.09 -1.7 -1.95 -0.29 0.49
Hematopoietic Stem Cell Differentiation%WikiPathways_20191210%WP2849%Homo sapiens 6.73 6.04 1.26 7.3 -1.37 -4.31 -0.52 -2.22 -1 -1.73 3.17 -2.1 -2.48 -1.75 -1.71 -2.22 3.51 2.61 0.46 -1.82 4.24 0.04 -2.78 -7.65 -1.15 -0.54
Methionine De Novo and Salvage Pathway%WikiPathways_20191210%WP3580%Homo sapiens -5.37 -4.02 5.83 2.66 -2.37 -0.64 -0.08 -0.54 0.37 0.74 2.57 0.14 0.9 0.24 0.49 2.11 -2.69 -2.94 -0.93 0.54 -2.7 0.14 2.29 2.59 0.9 -0.25
TP53 Network%WikiPathways_20191210%WP1742%Homo sapiens -2.76 -1.35 -4.66 -5.6 2.22 3.93 -0.4 1.24 -0.48 2.35 -2.81 1.27 2.74 2.19 1.54 -0.62 -1.44 -1.55 0.33 1.47 -2.61 0.59 1.56 3.96 0.03 -1.14
GABA receptor Signaling%WikiPathways_20191210%WP4159%Homo sapiens 3.42 1.49 -1.25 4.69 1.27 -2.95 -4.53 0.07 -2.27 -3.32 2.63 2.71 -1.72 -2.14 -3.31 -1.44 5.59 3.78 -0.67 -1.22 3.4 0.8 -3.53 -3.64 -0.62 2.76
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition%WikiPathways_20191210%WP3859%Homo sapiens -1.59 -0.22 -2.21 -7.27 1.09 1.76 2.11 0.61 1.42 0.08 -2.24 -0.43 0.67 1.2 -0.23 0.45 -0.96 -2.22 -0.07 0.8 1.02 0.39 3.33 3.43 -0.02 -0.9
Valproic acid pathway%WikiPathways_20191210%WP3871%Homo sapiens -5.42 -4.49 0.93 -0.13 1.39 0.91 -0.27 1.09 -0.3 1.45 -0.93 0.5 0.52 1 0.03 1.79 0.04 -2.34 0.34 0.74 -2.64 1.04 0.67 1.92 0.94 1.19
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways%WikiPathways_20191210%WP706%Homo sapiens 6.02 3.34 7.15 15.95 -5.61 -8.66 -2.37 -1.59 -2.61 -3.79 6.12 -2.57 -4.41 -4.87 -0.52 -1.8 4.54 6.13 -2.68 -3.77 6.88 1.3 -3.6 -8.19 -1.18 0.79
Histone Modifications%WikiPathways_20191210%WP2369%Homo sapiens -0.38 -0.06 7.75 7.44 -3.02 -3.83 -0.2 0.21 1.01 -1.02 3.54 -1.08 -2.66 -2.64 0.04 0.52 -1.06 -0.32 -2.24 -2.1 1.47 0.73 0.1 -0.43 -0.68 -1.11
Pathways in clear cell renal cell carcinoma%WikiPathways_20191210%WP4018%Homo sapiens 5.49 4.72 7.04 13.86 -3.36 -4.22 -1.56 -1.51 -1.06 -2.2 6.1 -1.03 -4.61 -4.83 -0.64 -0.58 0.01 1.76 -0.76 -2.3 2.06 0.02 -3.11 -5.98 -2.11 -1.17
miRNAs involved in DNA damage response%WikiPathways_20191210%WP1545%Homo sapiens -3.32 -2.49 -2.58 -4.52 1.06 1.79 1 0.73 2.02 1.45 -1.23 1.33 2.2 1.96 0.11 -0.85 0.22 -1.37 -0.77 1.64 -2.11 -0.98 1.23 3.09 0.26 0.11
Zinc homeostasis%WikiPathways_20191210%WP3529%Homo sapiens -1.84 -1.43 -4.09 -4.84 4.2 4.79 0.57 -0.83 1.53 3.36 -2.82 0.63 2.48 3.07 -0.22 0.21 -1.99 -2.02 1.45 1.11 -5.99 -3.41 3.41 4.2 -0.33 -1.2
BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation%WikiPathways_20191210%WP3876%Homo sapiens 1.41 1.55 3.37 5.12 0.1 -1.03 -1.08 -2.9 2.19 -1.73 2.47 -1.63 -1.7 -0.18 -1.91 -1.56 1.01 1.81 0.77 -0.65 -0.43 -2.38 -0.61 -1.52 -0.35 -0.11
Alzheimers Disease%WikiPathways_20191210%WP2059%Homo sapiens 1.62 0.03 6.35 13.7 -4.88 -6.33 -1.79 -0.13 -2.11 -3.5 4.11 -2.29 -2.94 -3.29 -1.07 0.03 4.41 3.98 -4.3 -3.71 5.85 4.06 -3.49 -5.62 -0.57 1.87
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway%WikiPathways_20191210%WP2203%Homo sapiens 6.78 5.41 2.61 4.38 -1.87 -5.01 -1.47 0.81 -1.71 -3.92 2.33 -1.6 -1.63 -2.57 -1.69 -1.61 2.42 3.6 -1.53 -0.24 5.23 0.76 -3.99 -6.01 -1.05 1.56
Imatinib and Chronic Myeloid Leukemia%WikiPathways_20191210%WP3640%Homo sapiens -1.51 -1.98 -4.61 -7.87 1.58 1.6 -0.26 1.38 0.39 0.35 -3.51 1.34 1.99 1.75 -0.43 -0.71 2.31 2.16 1.86 0.2 0.41 0.32 0.45 1.92 -0.19 1.06
Eicosanoid Synthesis%WikiPathways_20191210%WP167%Homo sapiens -6.22 -2.5 -1.8 -1.98 0.93 1.95 1.31 -0.28 1.73 1.81 -0.83 0.86 1.27 2.25 -0.06 0.02 -1.63 -1.31 -0.02 0.22 -2.03 -1.26 2.98 4.03 0.57 -0.01
Signaling of Hepatocyte Growth Factor Receptor%WikiPathways_20191210%WP313%Homo sapiens -0.34 -1.53 -3.81 -3.92 5.21 4.23 0.34 -2.06 3.21 2.2 -0.3 2.38 2.43 1.99 -1.27 -2.46 -0.09 -3.47 1.59 0.99 -4.63 -4.18 3.05 3.94 -1.27 -2.27
Signal Transduction of S1P Receptor%WikiPathways_20191210%WP26%Homo sapiens 0.02 1.01 -3.07 -7.03 3.8 3.66 -0.35 -0.86 1.47 1.39 -2.89 1.6 1.04 2.08 -0.37 -1.05 -1.71 -0.93 2.78 2.04 -3.55 -2.82 1.65 3.96 -0.14 -1.72
Selenium Micronutrient Network%WikiPathways_20191210%WP15%Homo sapiens -8.69 -6.25 -2.38 -6.57 3.68 6.24 1.97 -0.65 2.02 3.57 -3.06 0.28 4.51 4.01 1.43 2.02 -3.79 -5.86 -3.02 0.45 -4.87 0.56 4.32 6.21 2.98 0.89
Eukaryotic Transcription Initiation%WikiPathways_20191210%WP405%Homo sapiens -6.22 -4.97 7.54 9.06 -3.42 -2.84 -0.44 1.03 0.84 0.3 2.11 -0.08 -1.43 -0.84 1.96 1.83 -2.03 -3.09 -4.76 -0.55 -0.25 1.32 1.5 2.33 0.62 0.52
Wnt Signaling Pathway and Pluripotency%WikiPathways_20191210%WP399%Homo sapiens -3.2 -1.17 -7.3 -13.07 4.79 7.55 1.69 1.01 0.38 2.75 -6.61 2.52 3.92 4.05 0.67 -0.52 -2.99 -1.89 3.11 3.95 -5.53 -1.67 1.93 6.38 0.26 -1.03
Glutathione metabolism%WikiPathways_20191210%WP100%Homo sapiens -0.21 -1.42 1.84 4.95 -3.95 -3.77 0.03 1.08 -1.88 -0.47 0.36 1.13 -2.3 -1.41 1.02 -0.05 2.05 1.35 -1.95 0.33 3.52 2.62 -1.23 -2.95 0.58 0.74
NOTCH1 regulation of human endothelial cell calcification%WikiPathways_20191210%WP3413%Homo sapiens 1.56 2.37 1.32 4.85 -1.55 -0.84 0.23 0.26 0.23 -1.68 0.53 -1.32 -1.13 -0.7 1.73 0.68 0.48 3.97 0.96 -1.68 -1.38 -2.08 -2.81 -1.94 -0.98 -1.11
Role of Osx and miRNAs in tooth development%WikiPathways_20191210%WP3971%Homo sapiens -4.62 -3.64 -1.25 -5.04 1.57 1.98 -0.95 -0.48 -1.62 1.31 -2.92 2.42 2.33 1.67 0.43 2.54 -1.63 -2.72 0.28 1.46 0.19 2.09 1.44 3.76 1.18 0.2
Deregulation of Rab and Rab Effector Genes in Bladder Cancer%WikiPathways_20191210%WP2291%Homo sapiens -2.29 -1.92 -2.73 -4.38 0.6 3.13 1.56 0.8 0.04 1.62 -0.96 0.73 0.53 1.14 2.32 0.53 -2.31 -1.35 0.79 1.75 -2.25 -1.12 2 2.85 0.7 -1.78
IL-5 Signaling Pathway%WikiPathways_20191210%WP127%Homo sapiens -3.83 -1.63 -3.36 -7.22 2.34 3.81 2.37 -1.21 3.22 2.88 -1.96 1.36 3.06 3.41 1.62 -0.3 -1.47 -2.8 1.57 0.39 -4.88 -2.31 3.72 5.05 0.05 -3.87
SRF and miRs in Smooth Muscle Differentiation and Proliferation%WikiPathways_20191210%WP1991%Homo sapiens -0.62 -0.48 -3.37 -5.02 -1.02 -0.72 -1.44 0.9 -0.62 -2.19 -2 1.02 1.79 2.39 1.12 1.37 -0.68 1.07 -0.19 1.14 0.76 0.4 -0.11 2.05 2.23 2.22
Sterol Regulatory Element-Binding Proteins (SREBP) signalling%WikiPathways_20191210%WP1982%Homo sapiens -7.56 -6.85 2.96 1.86 1.46 1.7 3.33 1.15 4 4.32 -1.91 -1.84 3.36 2.77 1.94 0.85 -3.75 -7.77 -3.36 -0.6 -6.04 -2.78 6.03 5.98 1.65 -0.87
GPCRs, Class A Rhodopsin-like%WikiPathways_20191210%WP455%Homo sapiens -18.11 -12.63 -0.33 -8.23 5.12 10.57 1.67 1.46 0.49 5.94 -5.95 0.6 6.98 6.12 4.62 5.59 -9.65 -12.23 -0.81 4.79 -10.66 1.92 6.54 10.78 3.82 1.58
Allograft Rejection%WikiPathways_20191210%WP2328%Homo sapiens 11.46 7.99 0.18 5.12 -2.63 -6.25 -2.05 -0.38 -1.67 -2.9 3.76 -0.66 -4.17 -4.24 -3.03 -1.35 5.23 7.71 0.7 -2.23 5.87 -0.31 -4.78 -7.41 -3.59 -0.38
IL1 and megakaryocytes in obesity%WikiPathways_20191210%WP2865%Homo sapiens -3.01 -2.92 -2.34 -2.49 1.85 3.81 1.26 0.49 0.05 2.5 -1.69 1.18 2.42 1.72 1.77 1.42 -1.52 -2.16 2.73 0.7 -3.75 -1.89 1.94 3.66 -2.56 -3.15
Chemokine signaling pathway%WikiPathways_20191210%WP3929%Homo sapiens 9.99 6.72 3.65 11.89 -5.7 -7.59 -2.42 0.34 -5 -2.98 3.71 -1.07 -5.35 -5.81 -3.7 -2.95 5.29 7.95 0.08 -4.26 8.9 0.94 -5.8 -7.84 -0.5 1.5
MECP2 and Associated Rett Syndrome%WikiPathways_20191210%WP3584%Homo sapiens -2.13 -2.16 -5.41 -12.51 4.68 5.53 2.58 0.27 3.63 2.71 -4.22 1.72 3.6 3.08 -0.21 0.08 -1.81 -4.2 2.25 2.74 -4.97 -3.4 3.36 6.45 0.04 -1.7
Focal Adhesion%WikiPathways_20191210%WP306%Homo sapiens -7.95 -5.12 -6.09 -13.74 7.1 9 1.07 -3.06 5.25 4.75 -4.34 2.53 6.44 7.43 -1.69 0.41 -3.05 -7.68 0.52 3.77 -7.8 -3.35 6.76 9.14 1.43 -1.73
miRs in Muscle Cell Differentiation%WikiPathways_20191210%WP2012%Homo sapiens -2.26 -1.73 -3.32 -9.28 0.85 2.86 0.24 1.67 1.05 0.57 -3.16 0.84 1.79 3.4 1.83 0.97 -3.57 -1.9 2.11 1.98 -1.86 -0.84 2.19 4.36 0.94 0.27
Primary Focal Segmental Glomerulosclerosis FSGS%WikiPathways_20191210%WP2572%Homo sapiens -3.98 -3.39 -5.88 -13.23 3.57 4.91 0.78 -0.35 -0.35 1.61 -4.5 2.27 4.16 4.62 -1.35 0.41 -2.51 -4.49 0.86 2.02 -0.48 1.62 4.43 5.33 2.32 1.6
Glucuronidation%WikiPathways_20191210%WP698%Homo sapiens -5.91 -5.7 0.97 -1.77 0.52 2.58 2.41 -1.26 2.49 2.55 -1.78 -0.96 3.2 3.78 2.25 0.71 -2.02 -3.63 -2.75 -0.68 -3.89 0.49 2.75 2.9 2.32 0.45
Genes targeted by miRNAs in adipocytes%WikiPathways_20191210%WP1992%Homo sapiens 0.2 0.31 -1.24 -1.29 2.4 3.24 1.19 0.08 1.21 2.76 -2.86 0.48 1.89 0.93 1.22 -1.68 -2.67 -1.94 1.12 2.56 -4.02 -2.18 0.74 2.05 -1.73 -2.79
mRNA Processing%WikiPathways_20191210%WP411%Homo sapiens -5.43 -3.65 -3.44 -9.12 3.98 5.74 1.78 -2.96 5.46 4.47 -3.91 2.79 5.44 4.88 1.69 0.72 -5.62 -6.91 -0.11 0.32 -7.16 -4.23 7.25 8.23 2.58 -2.79
Wnt/beta-catenin Signaling Pathway in Leukemia%WikiPathways_20191210%WP3658%Homo sapiens 1.85 0.23 3.15 7.9 -2.14 -2.79 -1.19 0.13 0.04 -0.73 2.16 -1.31 -2.02 -2.62 -1.11 -0.07 1.11 2.11 -1.62 -1.38 2.04 -0.65 -1.24 -2.95 0.26 0.83
RalA downstream regulated genes%WikiPathways_20191210%WP2290%Homo sapiens -4.66 -3.26 1 0.49 -0.7 0.2 0.07 -0.03 2.01 1.42 -0.41 -0.19 2.42 2.18 1.97 1.85 -1.63 -1.46 -1.9 -0.48 -3.68 0.32 1.19 2.35 0.81 0.11
EBV LMP1 signaling%WikiPathways_20191210%WP262%Homo sapiens -4.5 -3.12 -1.16 -3.36 2.02 3.45 0.15 0.21 1.18 1.97 -0.2 0.32 1.43 2.39 1.33 0.92 -2.69 -3.25 1.96 -0.04 -2.9 -1.66 2.49 3.8 0.45 -1.17
Farnesoid X Receptor  Pathway%WikiPathways_20191210%WP2879%Homo sapiens -6.33 -4.47 -1.03 -4.62 1.22 3.27 0.46 0.9 1.14 2.05 -2.13 0.94 2.62 3.06 1.78 0.82 -0.49 -3.95 -1.47 0.28 -2.61 0.94 2.49 2.7 1.61 0.82
Hepatitis C and Hepatocellular Carcinoma%WikiPathways_20191210%WP3646%Homo sapiens -6.57 -6.03 -1.19 -4.98 2.36 4.51 1.24 0.72 2.05 3.73 -1.94 0.76 3.37 2.83 2.34 0.24 -2.94 -5.64 -0.07 1.56 -5.08 0.65 2.1 5.32 1.53 -0.88
Transcription factor regulation in adipogenesis%WikiPathways_20191210%WP3599%Homo sapiens -4.65 -3.26 1.98 -0.58 -2.77 -1.2 -0.04 0.84 -0.14 -0.14 -2.39 0.58 0.74 -1.33 2.22 0.72 -1.24 -0.78 -3.98 -0.93 3.21 4.77 0.33 2.82 2.36 2.85
Electron Transport Chain (OXPHOS system in mitochondria)%WikiPathways_20191210%WP111%Homo sapiens -6.61 -3.49 11.84 7.82 -7.16 -6.28 -0.73 4.97 -1.32 -1.64 3.71 -2.41 -2.43 -1.78 3.15 5.56 -2.36 -3.51 -3.48 0.77 -0.3 4.1 -0.83 1.37 -0.09 1.14
Melatonin metabolism and effects%WikiPathways_20191210%WP3298%Homo sapiens -4.95 -3.8 -3.31 -6.48 0.45 2.21 0.64 2.3 -0.47 0.96 -4.35 -0.68 2.11 2.66 1.56 0.1 -0.17 -1.83 0.18 2.31 -0.56 1.57 0.57 5.31 2.23 1.43
AGE/RAGE pathway%WikiPathways_20191210%WP2324%Homo sapiens -6.01 -3.75 -2.68 -9.07 3.45 3.78 1.78 -1.05 3.52 1.87 -2.32 0.46 3.72 3.66 1.15 -0.21 -1.4 -4.51 -0.57 1.88 -2.24 -0.6 4.73 5.16 1.08 -1.79
miR-509-3p alteration of YAP1/ECM axis%WikiPathways_20191210%WP3967%Homo sapiens 1.54 1.33 1.93 3.3 -3.2 -3.84 0.25 -0.25 -1.43 -1.19 2.19 0.13 -2.66 -2.59 1.62 -0.17 0.4 1.81 -1.67 -2.88 2.58 2.54 0.01 -3.1 1.61 1.75
Nucleotide GPCRs%WikiPathways_20191210%WP80%Homo sapiens -3.88 -3.54 2.5 0.69 -0.67 0.87 0.75 0.35 0.09 1.39 0.49 0.32 0.3 1.68 1.45 1.38 -2.89 -3.08 0.13 -0.27 -1.57 1.18 1.91 1.6 -0.17 -1.04
Translation Factors%WikiPathways_20191210%WP107%Homo sapiens -5.87 -4.41 6.63 7.13 -3.69 -2.67 0.7 1.2 0.2 0.88 2.94 -0.24 -0.7 -0.62 0.7 0.42 -2.81 -3.42 -3.15 -0.35 2.15 2.38 1.06 1.78 -0.06 -0.17
Estrogen metabolism%WikiPathways_20191210%WP697%Homo sapiens -4.07 -3.1 0.82 -1.47 0.72 2.09 2.47 -0.08 0.56 2.35 -0.5 0.43 1.56 2.13 0.74 0 -1.26 -4.17 -2.64 -0.42 -2.86 0.28 1.63 2.63 1.22 0.93
miRNA regulation of p53 pathway in prostate cancer%WikiPathways_20191210%WP3982%Homo sapiens 2.01 2.32 1.43 4.9 -1.06 -3.71 -0.35 0.67 -1.07 -2.73 0.55 -1.16 -2.51 -3.02 0.87 0.82 3.27 3.03 -1.72 -1.72 3.52 0.34 -3.65 -4.6 0.98 2.58
G Protein Signaling Pathways%WikiPathways_20191210%WP35%Homo sapiens 2.88 1.88 5.49 15.71 -4.01 -4.46 -1.67 0.87 -3.62 -2.02 3.27 -1.39 -3.68 -5.17 -1.11 -1.82 4.63 2.77 -3.14 -3.17 4.62 1.86 -4.22 -6.93 -0.56 3
Differentiation Pathway%WikiPathways_20191210%WP2848%Homo sapiens -6.51 -4.79 -1.21 -8.19 1.49 4.01 1.42 1.41 -0.97 2.78 -3.31 2.63 3.23 2.46 0.68 1.59 -1.92 -3.6 -0.32 1.95 -3.64 1.62 2.44 4.82 1.03 0.9
Nuclear Receptors Meta-Pathway%WikiPathways_20191210%WP2882%Homo sapiens 16.47 11.27 4.22 14.82 -7.62 -11.47 -1.74 -0.34 -3.59 -6.05 7.18 -0.44 -8.11 -8.29 -1.09 -2.2 5 12.25 0.43 -3.83 10.58 -0.66 -8.5 -13.07 -4.12 -1.1
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection%WikiPathways_20191210%WP3863%Homo sapiens 7.31 4.77 2.52 5.46 -3.47 -5.17 -2.69 0.69 -1.92 -2.4 2.01 0.66 -4.75 -4.69 -3.46 -0.45 2.66 5.85 0.29 -0.52 6.56 1.46 -3.45 -5.42 -2.03 0.2
Overview of leukocyte-intrinsic Hippo pathway functions%WikiPathways_20191210%WP4542%Homo sapiens -6.47 -2.98 -1.14 -4.97 1.43 2.16 -0.7 1.08 0.26 0.53 -1.46 0.93 1.81 1.62 0.62 1.6 1.47 -4.38 -1.05 1.3 -1.6 1.72 3.72 3.79 0.68 0.03
TGF-beta Signaling Pathway%WikiPathways_20191210%WP366%Homo sapiens -0.51 -0.92 -7.84 -10.52 8.52 9.34 3.13 -2.26 4.9 3.24 -2.21 2.35 3.54 3.97 -0.99 -1.73 -2.91 -3.71 5.17 2.85 -9.34 -6.66 3.86 6.28 -1.85 -5.7
ATM Signaling Pathway%WikiPathways_20191210%WP2516%Homo sapiens 4.35 3.06 2.94 5.36 -4.07 -5.34 -2.01 1.69 -2.45 -3.07 2.53 -1.46 -2.77 -3.15 -0.99 0.22 2.54 4.05 -1.15 -2.18 6.47 1.71 -3.29 -3.9 -0.41 1.31
Toll-like Receptor Signaling Pathway%WikiPathways_20191210%WP75%Homo sapiens -10.15 -7.6 0.57 -2.61 1.12 5.13 1.59 -0.84 4.05 4.19 -1.83 0.8 2.43 4.05 4.11 1.17 -4.86 -7.29 -0.65 1.56 -6.53 -1.31 6.81 7.45 1.75 -3.09
Interferon type I signaling pathways%WikiPathways_20191210%WP585%Homo sapiens -6.78 -3.52 -2.92 -6.1 1.84 3.46 1.79 -0.78 4.14 3.31 -2.52 2.79 3.12 4.11 1.03 0.34 -0.21 -5.56 -0.86 1.24 -4.33 -1.51 4.01 5.02 0.14 -1.23
Oxidative phosphorylation%WikiPathways_20191210%WP623%Homo sapiens -5.5 -2.57 10.41 6 -4.78 -3.59 0.27 3.19 -0.91 -0.59 2.48 -2.15 -1.98 -0.46 1.84 3.92 -2.18 -2.45 -2.53 0.31 -1.61 2.77 -0.89 1.28 -0.73 0.45
Photodynamic therapy-induced AP-1 survival signaling.%WikiPathways_20191210%WP3611%Homo sapiens 5.44 5.16 1.76 5.13 -1.9 -3.48 -2.29 -0.19 -3.15 -3.57 2.55 -0.38 -3.9 -2.91 -1.09 0.5 2.27 3.2 0.76 -2.27 3.9 1.36 -4.31 -4.38 -0.49 2.3
NAD metabolism, sirtuins and aging%WikiPathways_20191210%WP3630%Homo sapiens -4.24 -3.01 -1.76 -1.6 0.6 0.63 -0.48 0.01 1.32 0.88 -1.01 -0.12 2.63 1.88 2.07 1.37 -1.1 -4.32 -1.42 -0.45 -2 2.14 1.85 2.42 2.12 1.59
Fatty Acid Biosynthesis%WikiPathways_20191210%WP357%Homo sapiens -2.58 -1.9 -5.79 -5.48 3.78 2.42 1.39 1.07 1.79 2.19 -2.2 0.22 2.24 1.9 0.78 -0.37 -0.56 -2.55 0.41 0.85 -1.71 -0.94 1.07 2.04 0.87 1.04
Corticotropin-releasing hormone signaling pathway%WikiPathways_20191210%WP2355%Homo sapiens 1.41 1.63 4.96 8.31 -6.34 -6.65 -2.01 2.64 -4.84 -4.07 1.64 -2.38 -3.53 -4.07 -0.82 0.6 2.22 4.61 -3.18 -1.75 8.25 5.93 -3.95 -5.88 2.23 5.04
GPCRs, Class C Metabotropic glutamate, pheromone%WikiPathways_20191210%WP501%Homo sapiens 0.9 0.43 2.88 8.25 -1.53 -2.92 -1.95 -0.44 -0.99 -1.52 2.55 -0.64 -2.34 -1.84 -0.29 -0.92 2.45 1.61 -2.33 -1.51 2.04 1.23 -1.62 -2.46 -0.44 1.39
Amplification and Expansion of Oncogenic Pathways as Metastatic Traits%WikiPathways_20191210%WP3678%Homo sapiens -1.6 -0.9 -3.17 -5.53 -0.07 -0.4 0.51 1.93 0.4 -0.09 -2.59 -1.52 1.51 1.49 -0.15 0.83 1.86 -0.4 -1.55 1.29 2.31 3.67 1.12 -0.46 0.31 1.2
Exercise-induced Circadian Regulation%WikiPathways_20191210%WP410%Homo sapiens -4.44 -4.29 2.2 0.13 0.49 1.68 0.94 -2.73 4.41 3.09 2.45 -0.11 2.98 2.75 1.26 0.41 -2.58 -5.03 -1.72 -0.89 -3.46 -0.89 5.6 3.39 -1.08 -4.57
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities%WikiPathways_20191210%WP3844%Homo sapiens -0.58 -1.42 -0.4 3.76 3.11 3.31 0.69 -3.03 3.49 1.55 0.76 -0.51 2.17 1.91 -0.8 -0.94 -2.81 -3.16 0.34 0.16 -6.08 -4.21 3.54 2.85 -0.85 -2.85
Neural Crest Differentiation%WikiPathways_20191210%WP2064%Homo sapiens 5.56 4.42 6.32 14 -4.85 -6.67 -0.09 -2.02 0.11 -2.84 7.05 -4.15 -3.51 -2.92 1.96 0.36 -1.52 2.9 -0.39 -3.01 1.38 -0.39 -2.79 -6.16 -1.27 -1.5
Apoptosis Modulation by HSP70%WikiPathways_20191210%WP384%Homo sapiens -2.16 -2.05 -2.2 -2.93 1.35 3.4 1.54 0.81 0.92 3.4 -2.12 0.8 2.5 1.97 0.79 -0.91 -2.51 -1.85 1.05 1.6 -4.28 -0.97 1.37 3.16 -0.12 -2.57
Serotonin Transporter Activity%WikiPathways_20191210%WP1455%Homo sapiens -1.87 -1.62 2.58 1.76 1.74 0.69 -0.23 0.98 -0.41 1.64 1.14 -0.21 0.25 1.04 0.77 3.43 -3.61 -1.62 0.03 -0.06 -0.62 -0.38 -1.47 0.79 -2.14 -2.61
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway%WikiPathways_20191210%WP2036%Homo sapiens 4.67 4.74 -0.69 1.03 -0.83 -3.11 -0.69 1.34 -3.72 -2.81 -1.94 0.12 -1.2 -2.15 -1.99 -1.29 3.05 4.3 -1.16 0.59 5.37 2.42 -3.93 -4.03 -0.12 2.04
NRF2 pathway%WikiPathways_20191210%WP2884%Homo sapiens 10.66 7.11 1.14 8.87 -4.37 -6.22 0.33 -0.1 -1.21 -4.19 4.47 -0.12 -4.5 -4.24 -0.14 -2.42 4.17 7.93 0.28 -3.43 6.56 -0.59 -5.66 -8.87 -3.1 -2.36
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)%WikiPathways_20191210%WP2817%Homo sapiens -3.89 -2.37 -4.1 -6.19 3.62 4.76 0.58 -1.71 1.39 1.57 -2.01 0.31 3.13 3.38 -0.28 -0.47 -0.74 -3.08 0.57 1.43 -3.62 -1.06 2.33 4.42 1.83 0.18
RAC1/PAK1/p38/MMP2 Pathway%WikiPathways_20191210%WP3303%Homo sapiens 6.21 3.58 1.39 5.2 -4.22 -5.51 -0.55 3.41 -3.61 -3.46 1.03 -1.47 -4.35 -4.54 -1.6 0.22 2.92 4.84 -1.14 -0.67 7.31 2.57 -4.47 -6.15 0 3.04
Synaptic Vesicle Pathway%WikiPathways_20191210%WP2267%Homo sapiens 6.16 3.85 2.89 3.56 2.2 -0.41 -3.75 -5.18 0.57 -2.25 4.85 0.98 -1.76 -1.38 -3.89 -1.74 2.33 1.44 1.58 -3.75 2.31 -1.79 -0.29 -2.87 -2.68 -0.98
Ovarian Infertility Genes%WikiPathways_20191210%WP34%Homo sapiens 6.45 3.3 1.8 4.77 -3.68 -4.01 -1.13 0.89 -1.91 -2.35 3.38 1.14 -3.83 -2.74 -2.03 -1.92 2.5 3.77 2.48 -1.4 3.39 -0.88 -2.59 -3.67 -1.38 -0.35
TCA Cycle (aka Krebs or citric acid cycle)%WikiPathways_20191210%WP78%Homo sapiens -1.87 -0.3 -3.16 -5.76 -2.12 -1.86 -0.55 0.48 0.14 -0.47 -1.61 0.23 0.62 1.15 -0.12 1.96 1.68 1.77 -0.67 -0.03 2.69 1.4 -0.2 0.11 2.95 3.56
Parkinsons Disease Pathway%WikiPathways_20191210%WP2371%Homo sapiens 2.19 2.42 1.24 3.17 -3.3 -4.2 -2.19 0.19 -3.84 -3.07 0.87 -0.07 -2.76 -2.14 -0.97 0.48 1.5 5.43 0.89 -2.75 6.25 3.72 -2.02 -1.46 -0.79 1.2
Arrhythmogenic Right Ventricular Cardiomyopathy%WikiPathways_20191210%WP2118%Homo sapiens 4.67 3.94 1.37 11.85 -2.63 -6.33 -2.04 1.04 -2.31 -3.8 3.11 -1.82 -2.85 -3.49 -0.98 -2.44 6.03 4.54 -2.55 -3.32 5.61 1.78 -3.58 -7.24 -0.32 1.77
MFAP5-mediated ovarian cancer cell motility and invasiveness%WikiPathways_20191210%WP3301%Homo sapiens -0.17 0.47 1.83 4.86 -1.93 -3.15 -1.21 -0.26 -0.79 -1.48 1.05 -1.18 -1.61 -1.55 -0.65 0.78 3.49 1.73 -0.77 -0.94 2.92 1.71 -0.77 -3.22 -0.39 1.25
Hair Follicle Development: Cytodifferentiation (Part 3 of 3)%WikiPathways_20191210%WP2840%Homo sapiens 5.69 6.08 3.99 9.3 -6.45 -7.61 1.12 0.45 -0.39 -4.25 4.33 -0.87 -5.19 -4.35 0.07 -2.44 2.33 6.79 -0.92 -3.02 7.58 0.2 -3.57 -6.36 -1.37 -1.15
Globo Sphingolipid Metabolism%WikiPathways_20191210%WP1424%Homo sapiens -1.38 -0.6 1.43 5.52 -2.64 -2.31 0.03 0.65 -1.68 -1.29 0.03 -0.8 -0.56 -1.94 1.08 -1.36 2.3 1.37 -2.04 -0.12 2.57 1.88 -1.37 -1.57 1.15 1.66
Urea cycle and metabolism of amino groups%WikiPathways_20191210%WP497%Homo sapiens 2.6 3.18 -5.37 -5.13 5.08 4.24 -0.08 -0.04 0.67 0.74 -1.8 0.92 0.9 0.51 -0.44 -0.94 -0.53 -0.03 1.62 -0.63 -1.9 -2.66 0.15 -0.22 -1.25 0.43
Non-homologous end joining%WikiPathways_20191210%WP438%Homo sapiens -3.38 -1.35 -2.61 -4 1.85 1.61 0.75 -0.28 0.63 1.41 -0.68 0.25 2.08 1.51 1.79 0.46 -1.9 -2.57 -0.88 -0.42 -0.58 0.52 1.71 2.37 1.84 -0.16
One Carbon Metabolism%WikiPathways_20191210%WP241%Homo sapiens 0.89 -0.37 -3.74 -8.24 3.75 3.46 -0.5 -0.4 0.44 1.14 -1.61 0.51 2.69 1.86 -1.07 -0.5 -1.49 -2.57 1.16 1.97 -2.61 -0.97 1.99 2.94 1.22 0.06
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity%WikiPathways_20191210%WP3969%Homo sapiens -0.64 -0.84 4.46 4.52 -1.86 -2.74 -1.42 -0.26 -2.24 -1.06 2.65 0.42 -1.7 -1.04 1.2 2.91 -0.65 0.23 0.13 -1.75 1.07 1.8 -1.1 -0.62 -1.13 -0.35
Overview of nanoparticle effects%WikiPathways_20191210%WP3287%Homo sapiens -4.75 -2.5 2.24 -1.23 -0.99 -0.47 0.98 0.85 -0.21 0.8 -0.43 1.25 1.2 0.19 1.25 1.62 -1.02 -2.06 -4.86 0.09 -0.68 1.53 0.68 1.96 2.29 2.27
Glycolysis and Gluconeogenesis%WikiPathways_20191210%WP534%Homo sapiens -6.16 -4.34 -0.77 -6.51 0.77 3.19 1.91 0.76 -0.35 3.17 -2.08 1.79 1.74 2.6 2.89 2.74 -3.83 -4.86 0.83 2.32 -4.68 -1.41 2.81 6.11 1.42 -0.06
Myometrial Relaxation and Contraction Pathways%WikiPathways_20191210%WP289%Homo sapiens -3.4 -0.52 -7.68 -16.7 5.22 7.98 1.72 -0.88 2.52 1.94 -3.95 2.5 5.17 5.95 -0.59 -0.45 -5.04 -2.63 5.25 5.07 -5.47 -2.8 4.69 8.46 -2 -4.37
Constitutive Androstane Receptor Pathway%WikiPathways_20191210%WP2875%Homo sapiens -5.36 -3.36 -3.61 -4.52 3.59 3.69 1.37 -0.07 1.93 2.68 -1.54 0.05 3.06 4.43 0.14 0.6 -1.92 -5.58 0.48 -0.28 -4.88 -0.14 3.1 3.48 2.25 0.42
Lung fibrosis%WikiPathways_20191210%WP3624%Homo sapiens 9.05 6.56 -0.08 4.55 -1.47 -4.86 -2.3 -2.05 -2.5 -3.13 2.75 0.29 -3.82 -2.15 -2.43 -1.1 2.73 5.71 0.94 -2.17 5.92 1.22 -4 -6.18 -1.29 -0.2
Simplified Depiction of MYD88 Distinct Input-Output Pathway%WikiPathways_20191210%WP3877%Homo sapiens -3.27 -3.64 -1.16 -2.86 1.12 3.35 2.23 0.59 0.33 0.89 -3.19 0.74 1.87 0.73 2.83 0.62 -1.1 -1.49 1 -0.28 -2.94 -0.66 2.59 2.2 -0.47 -0.06
Nanomaterial induced apoptosis%WikiPathways_20191210%WP2507%Homo sapiens -3.36 -3.52 -0.71 -3.31 -0.11 1.59 2.98 1.17 1.56 3.3 -3.09 0.73 2.26 1.21 1.82 -1.11 -3.01 -1.97 -0.94 0.5 -1.98 0.45 2.88 3.39 0.89 -1.64
Blood Clotting Cascade%WikiPathways_20191210%WP272%Homo sapiens 6.45 3.85 0.28 2.41 -2.5 -4.27 -1.1 0.61 0.08 -2.15 4.12 -0.59 -2.49 -3.31 -1.15 -1.69 2.24 3.85 1.15 -1.89 3.91 0.63 -1.73 -3.99 -1.72 -0.99
Ethanol metabolism resulting in production of ROS by CYP2E1%WikiPathways_20191210%WP4269%Homo sapiens 1.49 0.34 -2.97 -2.07 2.98 3.34 -0.76 -1.53 0.19 0.37 -1.67 0.51 0.98 0.3 -1.29 -2.14 1.12 -0.6 1.8 1.38 -2.12 -2.04 0.36 2.03 -0.19 0.19
Insulin Signaling%WikiPathways_20191210%WP481%Homo sapiens -5.57 -2.07 -7.18 -16.15 6.08 7.31 2.07 -1.49 4.7 4.64 -4.6 3.66 4.87 5.82 1.6 0.25 -3.71 -5.37 3.92 3.3 -8.13 -3.89 5.41 8.39 0.43 -4.31
Sulfation Biotransformation Reaction%WikiPathways_20191210%WP692%Homo sapiens -5.07 -3.29 1.65 -0.85 -0.65 0.56 1.24 -1 1.52 2.02 -0.8 0.68 1.52 2.25 0.86 0.92 -1.44 -3.44 -2.19 -0.33 -2.37 0.18 1.71 3.03 2.15 1.14
Interactome of polycomb repressive complex 2 (PRC2) %WikiPathways_20191210%WP2916%Homo sapiens -4.85 -3.71 1.37 0.16 -0.52 0.48 0.36 0.26 1.65 1.41 1.4 -0.66 0.74 0.11 0.96 0.3 -1.2 -3.61 -3.25 -0.44 -1.01 0.41 3.19 3.44 2.48 0.51
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling%WikiPathways_20191210%WP732%Homo sapiens 1.46 -0.72 1.19 2.27 -0.7 -3.42 -0.69 1.66 -2.32 -1.23 0.84 -0.24 -2.07 -1.86 -1.75 -0.4 3.67 1.82 -2.07 -1.04 3.78 2.97 -3.09 -3.22 0.87 4.29
Nanoparticle triggered regulated necrosis%WikiPathways_20191210%WP2513%Homo sapiens -4.8 -3.76 -0.22 -1.71 -1 0.68 1.76 1.59 2.38 1.48 0.36 1.02 1.96 1.83 0.38 0.2 -2.04 -2.12 -1.63 0.64 -2.47 -0.93 2.09 3.92 0.74 -0.35
Nuclear Receptors in Lipid Metabolism and Toxicity%WikiPathways_20191210%WP299%Homo sapiens -5.75 -3.37 -2.68 -8.67 4.11 4.89 -0.89 0.48 0.83 2.44 -3.03 0.34 2.98 3.77 -0.19 1.04 -1.83 -4.68 1.03 1.3 -4.36 0.57 3.13 4.84 2.55 1.14
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)%WikiPathways_20191210%WP2453%Homo sapiens -3.37 -2.22 -0.94 -5.02 0.27 0.07 1.31 0 1.66 1.8 -1.29 0.56 1.51 1.79 1.19 2.26 -1.49 -1.23 0.73 1.6 -3.83 -2.77 1.96 2.76 2.08 0.61
DNA IR-damage and cellular response via ATR%WikiPathways_20191210%WP4016%Homo sapiens -6.34 -5.24 -2.73 -5.67 3.56 4.94 2.19 -0.34 3.57 3.89 -5.41 0.05 4.36 3.77 0.63 0.75 -4.37 -7.22 -0.05 2.33 -7.51 -0.55 5.89 7.21 2.22 0.07
Leptin signaling pathway%WikiPathways_20191210%WP2034%Homo sapiens -1.19 0.12 -5.3 -6.69 5.71 6.81 2.28 -4.45 4.3 3.19 -2.62 1.01 4.02 4.15 -1.3 -2.25 -1.38 -3.29 3.61 1.27 -7.5 -4.86 4.18 4.76 -0.99 -3.6
DNA Damage Response (only ATM dependent)%WikiPathways_20191210%WP710%Homo sapiens 5.44 3.76 6.37 9.42 -5.71 -8 -1.18 0.63 -1.76 -4.14 4.05 -2.19 -4.06 -4.48 -1.29 -0.43 4.07 5.36 -2.34 -2.78 6.78 2.25 -4.51 -7.87 -0.67 3.28
Cytoplasmic Ribosomal Proteins%WikiPathways_20191210%WP477%Homo sapiens -1.87 -0.76 8.53 12.25 -4.59 -3.92 1.03 1.57 -0.55 -1.34 3.55 -0.96 -2.5 -3.1 -0.33 0.43 -1.79 0.36 -2.64 -1.66 2.81 0.71 -1.9 -1.12 -1.3 -0.92
Estrogen Receptor Pathway%WikiPathways_20191210%WP2881%Homo sapiens -1.93 -0.92 -2.56 -5.13 1.5 2.12 0.29 -0.36 0.03 0.29 -1.87 1.18 2.03 1.52 -2.07 -2.01 1.51 -0.92 -0.79 0.68 -1.02 -1.13 1.75 4.03 2.27 1.52
Gastric Cancer Network 2%WikiPathways_20191210%WP2363%Homo sapiens -5.81 -4.15 0.86 -0.7 1.73 2.96 1.08 -0.31 0.69 3.56 -0.53 0.7 3.25 2.77 2.21 0.68 -2.87 -5.28 -1.28 0.28 -5.14 0.23 2.85 3.35 0.28 -1.42
Phytochemical activity on NRF2 transcriptional activation%WikiPathways_20191210%WP3%Homo sapiens 0.48 0.52 3.3 2.76 -2.29 -2.04 -0.11 1.37 -2.45 -1.63 -0.35 -0.22 -3.23 -2.47 1.04 0.55 0.77 -0.06 -1.13 -0.17 2.4 3.16 -2.4 -1.65 1.68 2.2
IL-7 Signaling Pathway%WikiPathways_20191210%WP205%Homo sapiens -1.5 -0.66 -2.98 -4.68 2.39 4 1.43 -1.87 1.52 1.97 -1.29 1.23 1.99 3.13 0.69 0.24 -1.43 -2.53 2.69 -0.57 -5.33 -2.56 2.69 3.49 0.54 -2.6
Tryptophan metabolism%WikiPathways_20191210%WP465%Homo sapiens -7.39 -4.84 -0.21 -3.58 2.78 4.63 1.31 -0.29 1.55 2.6 -1.63 0.94 3.38 3.8 1.92 0.37 -3.14 -6.22 -2.23 2.03 -5.17 -0.32 3.82 4.43 1.96 -0.5
Sphingolipid pathway%WikiPathways_20191210%WP1422%Homo sapiens 3.66 2.37 -0.01 0.79 -1.77 -1.9 -0.45 1.17 -3.33 -2.63 -0.67 -0.37 -2.97 -2.08 -0.26 0.62 1.22 4.65 1.39 -0.37 4.47 2.26 -3.58 -3.81 -0.53 2.13
Complement Activation%WikiPathways_20191210%WP545%Homo sapiens 3.81 2.43 1.65 2.25 -0.36 -2.12 -2.11 -1.37 -0.75 -1.95 -0.13 -2.94 -1.8 -1.94 -3.04 -0.66 2.4 1.89 -1.8 -1.22 3.02 1.09 -1.95 -3.59 3.78 5.39
Alpha 6 Beta 4 signaling pathway%WikiPathways_20191210%WP244%Homo sapiens 2.78 3.25 4.11 7.34 -3.17 -4 -0.72 0.23 -2.71 -0.77 1.71 -1.39 -3.14 -3.35 0.7 -0.68 1.13 3.48 -0.05 -0.3 2.61 0.17 -2.49 -3.06 -0.89 -0.78
Sleep regulation%WikiPathways_20191210%WP3591%Homo sapiens 6.25 2.28 -2.05 3.82 1.55 -1.92 -2.6 -0.74 -3.06 -1.55 2.47 0.77 -0.68 -1.67 -3.77 -1.73 5.59 2.17 0.03 -2.48 3.68 0.33 -2.3 -5.3 -1.05 1.95
Adipogenesis%WikiPathways_20191210%WP236%Homo sapiens 4.45 2.35 8.4 13.52 -6.14 -7.46 -2.25 -0.38 -2.76 -3.79 3.79 -0.91 -4.92 -5.02 0.37 -1.08 2.7 5.25 -4.09 -4.47 8.64 4.39 -4.25 -6.08 -1.32 1.09
Neovascularisation processes%WikiPathways_20191210%WP4331%Homo sapiens -3.53 -1.96 -4.45 -8.9 1.54 1.32 1.62 0.5 1.68 2.39 -3.35 0.93 2.04 1.34 1.38 0.42 -1.15 -1.72 1.39 1.52 0.25 0.37 2.63 4.13 0.37 -0.75
TYROBP Causal Network%WikiPathways_20191210%WP3945%Homo sapiens -1.2 -1.18 -5.6 -5.59 -0.74 1.81 1.88 0.69 -3.47 2.21 0.52 5.74 0.27 2.42 0.8 -0.45 1.09 2.03 6.54 0.98 -5.65 -3.8 1.5 4.71 -1.77 -3.72
Serotonin and anxiety%WikiPathways_20191210%WP3947%Homo sapiens 1.5 0.92 -0.66 5.49 0.19 -2.02 -1.88 -0.5 -1.61 -0.6 0.62 0.79 -0.58 -1.05 -2.21 -1.74 4.13 1.02 -0.62 -1.51 0.68 0.71 -2.18 -2.81 0.33 3.62
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma%WikiPathways_20191210%WP4337%Homo sapiens -1.71 -1.44 -3.33 -4.59 1.75 1.75 0.35 -0.29 1.86 1.25 -2.34 0.74 2.53 1.57 -1.35 1.28 0.14 -1.61 -0.26 0.06 -0.9 0.25 1.65 2.26 0.87 -0.49
Statin Pathway%WikiPathways_20191210%WP430%Homo sapiens -5.38 -2.84 -1.14 -4.97 1.34 3.71 1.1 -0.54 0.9 2.53 -2.85 0.24 2.13 2.04 1.33 1.23 -2.65 -4.66 0.58 1.13 -3.31 -0.31 3.3 4.87 1.45 0.76
Extracellular vesicle-mediated signaling in recipient cells%WikiPathways_20191210%WP2870%Homo sapiens 0.34 1.21 4.08 8.34 -4.55 -3.51 -1.85 2.31 -1.09 -0.17 1.22 0.71 -2.52 -3.71 2 -0.15 -0.7 0.38 -2.69 -0.71 1.13 1.41 -0.35 -1.98 -0.1 0.94
Leptin Insulin Overlap%WikiPathways_20191210%WP3935%Homo sapiens -3.68 -1.3 -4.07 -3.17 -0.66 -0.15 0.66 0.91 -0.51 1.24 -2.9 0.9 0.62 0.61 1.59 -0.14 1.09 -1.66 -0.78 1.32 1.21 1.4 1.34 3.42 2.08 0.64
ATM Signaling Network in Development and Disease %WikiPathways_20191210%WP3878%Homo sapiens 5.23 3.83 3.35 3.16 -2.76 -3.51 0.15 0.69 -2.52 -4.21 3.65 -2.11 -3.02 -3.65 -0.23 -0.62 4.17 5.8 -0.04 -0.74 3.75 -0.12 -4.17 -5.15 -0.72 -0.22
Bone Morphogenic Protein (BMP) Signalling and Regulation%WikiPathways_20191210%WP1425%Homo sapiens -3.11 -2.51 3.35 0.9 -1.69 0.2 2.23 -0.45 0.58 0.42 0.88 -1.16 0.7 1.82 1.13 0.45 -2.71 -2.36 -1.45 0 -0.42 -0.5 2.9 1.99 0.59 -1.78
Regulation of Actin Cytoskeleton%WikiPathways_20191210%WP51%Homo sapiens 6.63 5.29 5.75 17.06 -4.34 -6.91 -1.7 1.05 -2.98 -3.08 4.72 -3.07 -5.37 -5.48 -0.14 -1 2.3 6.15 -2 -4.52 6.38 1.38 -6.2 -7.98 -1.91 -0.02
Initiation of transcription and translation elongation at the HIV-1 LTR%WikiPathways_20191210%WP3414%Homo sapiens -1.99 -0.19 0.87 1.15 3.11 2.73 0.94 -2.13 3.6 1.36 1.73 0.19 1.31 0.91 -0.5 -0.54 -2.48 -3.1 0.92 0.29 -4.82 -3.43 4.38 2.9 -2.29 -4.92
Tumor suppressor activity of SMARCB1%WikiPathways_20191210%WP4204%Homo sapiens -0.43 0.24 -6.95 -10.63 1.36 2.65 0.74 2.11 -0.19 0.88 -4.37 0.08 1.79 1.59 1.78 -0.31 1.12 0.35 0.05 1.54 -0.29 0.59 -0.35 2.07 2.3 2.25
Bladder Cancer%WikiPathways_20191210%WP2828%Homo sapiens -1.4 -1.63 -2.91 -7.72 3.55 4.44 1.29 0.07 1.97 1.47 -3.98 0.6 3.28 2.96 0.55 -0.86 -2.09 -2.77 1.54 2.02 -2.96 -1.63 3.16 4.4 0.12 -3.49
miRNA Regulation of DNA Damage Response%WikiPathways_20191210%WP1530%Homo sapiens 5.12 5.35 4.61 9.03 -4.16 -6.2 -2.06 1.3 -3.16 -4.59 3.58 -1.5 -4.79 -4.96 -1.12 0.49 3.37 5.21 -0.9 -2.27 6.6 2.17 -5.53 -5.86 -1.28 1.57
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds%WikiPathways_20191210%WP3664%Homo sapiens -2.26 -1.26 -0.23 0.95 1.34 1.23 -1.02 -2.95 2.13 2.08 0.46 0.16 2.61 2.25 1.03 -0.1 -1.44 -2.49 1.1 -0.16 -3.82 -2.33 2.67 3.24 -0.43 -2.76
GPR40 Pathway%WikiPathways_20191210%WP3958%Homo sapiens -2.12 -1.51 -2.55 -4.8 3.37 3.01 0.54 0.94 0.45 1.92 -2.06 1.54 0.48 1.21 0.04 0.03 -1.26 -1.6 0.12 1.5 -2.69 -0.03 1.5 3.4 -0.89 -0.53
Development of pulmonary dendritic cells and macrophage subsets%WikiPathways_20191210%WP3892%Homo sapiens -4.46 -3.24 1.35 -1.48 0.75 3.47 1.32 -0.27 0.26 0.65 -1.07 -1.3 1.17 1.09 1.31 1.62 -3.07 -1.7 0.54 -0.8 -2.03 -0.06 1.83 3.31 0.51 0.3
Cell Differentiation - Index%WikiPathways_20191210%WP2029%Homo sapiens 2.32 1.22 4.2 6.18 0.51 -1.65 -0.27 -0.98 0.82 -1.06 3.5 -1.56 -2.13 -2.16 -0.5 -0.22 0.25 0.95 -1.04 -2.51 1.06 -0.33 -0.42 -2.97 -2.07 -1.13
Photodynamic therapy-induced NF-kB survival signaling%WikiPathways_20191210%WP3617%Homo sapiens 5.84 4.68 1.55 4.25 -3.64 -4.56 -1.32 -1.26 -2.32 -2.45 1.66 0.33 -2.53 -2.68 -1.98 -1.25 1.51 5.53 0.59 -0.52 3.79 0.64 -3.09 -4.4 0.25 1.38
ESC Pluripotency Pathways%WikiPathways_20191210%WP3931%Homo sapiens -6.18 -3.32 -6.67 -13.11 3.54 6.54 1.39 0.97 0.81 3.33 -6.92 3.2 4.55 4.25 -1 0.29 -0.17 -3.63 3.55 3.7 -5.86 -1.35 3.31 7.89 1.05 -0.16
NO/cGMP/PKG mediated Neuroprotection%WikiPathways_20191210%WP4008%Homo sapiens -5.15 -3.43 -3.28 -7.98 3.87 5.18 0.49 0.25 0.39 2.16 -1.65 2.59 2.85 2.33 1.44 1.59 -4.85 -3.96 2.62 1.77 -4.11 -1.17 3.17 4.94 0.37 -0.45
BDNF-TrkB Signaling%WikiPathways_20191210%WP3676%Homo sapiens 1.43 1.95 3.53 5.64 -3.95 -3.73 -0.86 0.4 -2.79 -2.34 2.14 -1.09 -2.35 -3.21 0.49 -1.03 1.22 3.48 -2.3 -0.75 5.08 3.14 -2.07 -2.89 -0.27 1.14
Regulation of Apoptosis by Parathyroid Hormone-related Protein%WikiPathways_20191210%WP3872%Homo sapiens -1.42 0.23 -1.7 -2.83 3.35 3.78 1.17 -1.69 1.2 2.8 -1.37 0.43 2.92 2.89 0.38 -0.61 -1.95 -2.36 1.19 1.61 -3.63 -1.65 0.89 2.89 -1.85 -4.68
Mammary gland development pathway - Involution (Stage 4 of 4)%WikiPathways_20191210%WP2815%Homo sapiens -1.34 -1.17 -2.67 -2.42 2.16 2.06 0.84 0.01 1.92 1.95 0.03 0.29 1.74 1.56 0.19 -0.22 -1.35 -2.57 0.16 0.76 -1.82 -0.96 2.08 3.13 -1.32 -3.02
IL-2 Signaling Pathway%WikiPathways_20191210%WP49%Homo sapiens -3.05 -1.91 -5.12 -7.33 2.71 4.19 1.64 -0.98 2.82 2.64 -2.84 1.54 2.58 3.9 1.38 0.32 -0.9 -2.89 2.69 0.1 -4.84 -2.83 3.01 5.01 0.68 -2.49
Leptin and adiponectin%WikiPathways_20191210%WP3934%Homo sapiens -2.81 -0.12 -1.83 -3.87 1.28 1.48 1.02 -1.21 1.21 0.66 -2.17 0.29 2.04 1.41 0.63 -0.8 -0.03 -1.61 0.23 0.68 -2.86 -0.13 0.96 2.35 1.44 1.76
Notch Signaling Pathway Netpath%WikiPathways_20191210%WP61%Homo sapiens 4.51 3.62 6.54 8.62 -4.22 -4.78 -0.98 0.02 -2.33 -2.2 5.21 -2.58 -3.79 -3.21 -0.49 0.15 1.55 3.88 -1.39 -2.3 2.83 0.3 -3.53 -5.58 -0.99 1.13
NAD+ metabolism%WikiPathways_20191210%WP3644%Homo sapiens -4.94 -4.57 0.36 -2.57 1.04 1.44 0 0.5 1.5 0.35 -1.15 -0.5 2.64 2 0.56 1.52 -0.86 -2.93 -1.62 0.52 -1.98 2.77 1.06 1.99 1.52 1.36
Prader-Willi and Angelman Syndrome%WikiPathways_20191210%WP3998%Homo sapiens -6.75 -4.08 0.79 -5.19 0.28 3.91 2.48 -1.79 3.14 3.29 -2.98 -1.54 4.09 4.04 2.26 0.75 -4.63 -5.95 -1.59 1.67 -3.77 0.58 5.13 5.37 1.83 -1.34
Structural Pathway of Interleukin 1 (IL-1)%WikiPathways_20191210%WP2637%Homo sapiens 3.58 3.18 -0.04 0.88 -3.55 -5.22 -1.38 2.64 -3.15 -2.91 -1.11 -0.25 -2.31 -3.37 -2.42 -2.11 4.76 4.02 -1.63 0.61 6.85 3.9 -3.44 -3.65 1.48 4.64
Mitochondrial Gene Expression%WikiPathways_20191210%WP391%Homo sapiens -1.25 -0.79 -0.91 -2.83 3.24 2.65 0.82 -2.26 2.03 1.43 0.4 0.75 2 2.37 -0.94 -0.54 -1.96 -2.82 1.19 -0.06 -4.21 -3.28 2.74 3.72 0.33 -1.82
Canonical  and Non-canonical Notch signaling%WikiPathways_20191210%WP3845%Homo sapiens -3.92 -3.74 -4 -5.4 2.22 2.43 -0.01 0.49 1.5 2.39 -2.96 2.11 2.03 1.24 0.85 -0.15 -2 -4.84 0.12 1.44 -0.98 1.47 2.78 3.66 1.45 1.84
Mesodermal Commitment Pathway%WikiPathways_20191210%WP2857%Homo sapiens -1.1 0.01 -10.76 -18.21 6.75 8.14 0.99 -0.97 0.28 2.95 -7.09 2.02 5.73 6.23 -1.33 -0.53 -0.17 -0.53 4.92 5.23 -5.71 -2.75 0.74 4.94 0.33 -0.12
PPAR Alpha Pathway%WikiPathways_20191210%WP2878%Homo sapiens -3.59 -1.45 -3.16 -7.35 0.4 3.29 -0.29 1.71 0.11 0.65 -3.27 0.97 1.66 1.52 1 1.1 1.06 -1.06 -1.78 1.11 0.61 0.45 1.2 3.4 1.14 0.57
PTF1A related regulatory pathway%WikiPathways_20191210%WP4147%Homo sapiens 1.92 3.59 1.89 3.27 -3.08 -3.54 1.32 -0.24 0.19 -0.68 1.45 -0.19 -2.07 -1.28 2.07 -0.7 0.63 1.91 -1.38 -1.36 2.29 0.06 -1.22 -2.86 -0.65 -1.32
Striated Muscle Contraction Pathway%WikiPathways_20191210%WP383%Homo sapiens -5.35 -4.8 -1.81 -7.61 1.78 3.89 -0.73 0 -0.96 1.96 -2.65 2.86 2.4 2.83 -0.98 0.25 -1.77 -3.3 0.98 1.57 -2.17 0.54 4.12 5.71 2.16 1.09
MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ%WikiPathways_20191210%WP3849%Homo sapiens -0.85 -1.14 -1.84 -1.69 0.88 2.57 0.68 -0.21 2.22 2.15 -0.8 0.06 0.55 1.17 1.84 0 -2 -3.08 0.97 -1.15 -3.02 -2.42 2.86 3.01 -0.42 -0.33
PPAR signaling pathway%WikiPathways_20191210%WP3942%Homo sapiens -6.34 -3.38 -4.02 -10.03 4.29 5.99 1.5 2.5 0.45 1.63 -4.63 0.6 3.54 3.52 0.87 1.77 -1.15 -4.71 0.4 3.26 -4.7 -0.05 2.83 4.94 1.01 -0.09
Selenium Metabolism and Selenoproteins%WikiPathways_20191210%WP28%Homo sapiens -0.72 -1 -6.78 -6.72 4.76 4.8 -0.16 -1.4 2.89 0.69 -2 1.05 3.38 2.6 -1.35 -0.35 0.37 -1.54 0.55 0.99 -3.38 -2.3 2.15 3.05 0.58 -0.16
Vitamin A and Carotenoid Metabolism%WikiPathways_20191210%WP716%Homo sapiens -4.84 -1.08 -1.76 -7.12 3.14 5.49 -0.1 -0.55 0.46 2.57 -2.51 1.91 1.28 2.29 1.6 1 -5.01 -3.48 1.62 2.34 -6.72 -1.23 2.6 5.5 2.36 0.24
PDGF Pathway%WikiPathways_20191210%WP2526%Homo sapiens 0.16 1.02 5.49 6.67 -4.61 -4.23 -1.35 1.91 -2.81 -1.25 -0.22 -2.04 -2.81 -2.51 0.3 0.26 0.21 2.42 -1.75 -0.66 4.12 2.33 -2.03 -1.8 1.09 2.07
Angiogenesis%WikiPathways_20191210%WP1539%Homo sapiens -0.89 -0.44 -5.19 -6.4 2.56 2.26 1.16 0.79 1.86 -0.85 -4.42 -1.4 3.18 2.85 -1.79 -1.74 2.79 -0.76 0.66 1.6 0.5 0.41 0.92 1.62 0.6 0.13
Liver X Receptor Pathway%WikiPathways_20191210%WP2874%Homo sapiens -4.94 -2.09 -1.85 -2.98 1.18 2.26 0.63 1.36 0.57 2.43 -2.06 0.36 1.69 1.42 1.86 0.63 -0.14 -3.7 -0.38 -0.03 -2.78 0.79 1.31 2.52 0.23 1.73
EDA Signalling in Hair Follicle Development%WikiPathways_20191210%WP3930%Homo sapiens 3.14 1.33 -0.63 4.55 0.41 -1.94 -0.48 0.92 -0.04 -1.93 2.22 0.08 -1.49 -1.91 -0.88 -1.06 2.57 1.75 -0.24 -0.08 1.3 0.3 -2.46 -4.3 -1.68 0.56
Regulation of toll-like receptor signaling pathway%WikiPathways_20191210%WP1449%Homo sapiens -11.92 -8.69 -0.65 -4.87 2.15 6.41 1.51 0.11 4.98 4.74 -2.69 1.17 3.33 4.47 4.18 1.39 -5.45 -8.68 -0.42 2.47 -8.51 -1.12 6.99 9.02 2.35 -2.26
IL17 signaling pathway%WikiPathways_20191210%WP2112%Homo sapiens -1.81 -0.63 -3.53 -5 3.27 4.4 1.99 -0.3 2.78 2.28 -2.69 0.16 2.39 3.1 0.71 -0.09 -2.47 -3.27 2.64 1.22 -4.22 -4.06 2.62 3.53 -0.93 -2.08
TLR4 Signaling and Tolerance%WikiPathways_20191210%WP3851%Homo sapiens 5.57 4.04 -1.96 -1.32 -0.03 -0.66 0.09 0.53 -2.15 -1.46 -0.41 -0.18 -1.17 -1.13 -1.52 -0.5 2.04 4.82 1.64 0.2 0.95 -1.25 -4.09 -3.12 -0.03 1.09
Oncostatin M Signaling Pathway%WikiPathways_20191210%WP2374%Homo sapiens -4.32 -4.6 -2.79 -3.9 4.36 4.85 0.82 -1.66 4.78 4.09 -0.35 1.21 2.97 4.56 0.57 2.22 -3.13 -5.36 1.89 1.26 -7.06 -3.45 4.95 4.89 -1.88 -4.9
ncRNAs involved in Wnt signaling in hepatocellular carcinoma%WikiPathways_20191210%WP4336%Homo sapiens -4.9 -1.68 -5.16 -11.91 2.37 5.9 0.13 2.96 -1.27 1.84 -7.24 2.41 2.54 2.14 1.63 0.61 -2.55 -3 1.75 3.71 -3.2 2.17 1.18 6.31 1.46 1.81
ERK Pathway in Huntington's Disease%WikiPathways_20191210%WP3853%Homo sapiens 0.86 1.45 1.43 4.08 -3.1 -2.82 -0.68 1.42 -1.74 -1.57 0.94 -0.95 -1.62 -2.03 1.57 -0.82 1.84 1.89 -1.87 -0.9 3.55 1.4 -1.63 -2.46 -0.08 1.84
miRNA targets in ECM and membrane receptors%WikiPathways_20191210%WP2911%Homo sapiens -4.85 -2.55 -0.11 -2.72 1.17 3.73 -0.89 -0.46 1.04 2.7 -2.4 -0.36 2.29 2.86 0.16 1.04 -1.93 -3.34 1.04 3.71 -5.25 -0.21 -2.89 5.06 2.33 0.82
Regulation of Microtubule Cytoskeleton%WikiPathways_20191210%WP2038%Homo sapiens 5.67 4.47 4.74 8.77 -3.61 -4.33 -1.76 -0.8 -0.95 -3.36 4.1 -0.92 -3.66 -3.55 -2.86 -1.22 1.66 2.66 -0.09 -0.37 2.69 0.55 -2.91 -4.88 -0.21 0.16
Pregnane X Receptor pathway%WikiPathways_20191210%WP2876%Homo sapiens 6.35 4.99 1.54 3.02 -3.57 -4.03 -1.3 0.66 -2.04 -3.01 1.3 0.26 -2.85 -4.43 -0.29 -0.73 2.54 6.49 0.14 0.03 5.69 -0.87 -3.68 -3.9 -2.09 -0.21
Non-genomic actions of 1,25 dihydroxyvitamin D3%WikiPathways_20191210%WP4341%Homo sapiens -3.16 -2.59 -2.62 -7.48 5.6 6.55 1.64 -1.19 3.14 3.32 -1.55 1.94 2.69 3.94 -0.61 0.16 -3.76 -4.3 2.87 2.85 -6.9 -5.19 3.78 5.43 -0.57 -3.97
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling%WikiPathways_20191210%WP3850%Homo sapiens -2.19 -1.05 -4.43 -8.5 4.37 2.86 1.56 -1.77 2.68 1.29 -2.43 1.04 2.69 3.23 -0.08 0.66 -1.24 -1.12 2.45 0.2 -2.99 -1.59 2.82 3.01 -0.68 -0.78
Amino Acid metabolism%WikiPathways_20191210%WP3925%Homo sapiens -7.89 -6.53 0.44 -5.64 0.69 4.11 2.95 -0.07 2.96 3.66 -2.94 -0.87 3.89 3.31 2.86 3.29 -4.74 -7.06 -0.2 2.4 -7.22 -1.76 4.6 6.42 2.82 0.51
Notch Signaling%WikiPathways_20191210%WP268%Homo sapiens 3.89 3.98 3.91 6.87 -4.14 -3.12 0.11 -0.14 -1.45 -2.39 2.84 -3.7 -3.02 -1.96 0.04 -0.03 1.72 3.85 -0.81 -1.63 2.09 0.47 -3.28 -4.6 0.09 0.4
Nanoparticle-mediated activation of receptor signaling%WikiPathways_20191210%WP2643%Homo sapiens 0.05 0.48 1.79 2.67 -3.08 -4.78 -0.58 3.41 -2.38 -1.45 1.26 -0.31 -1.74 -2.39 0.58 0.67 1.64 1.63 -3.8 -1.59 4.48 4.15 -1.68 -3.03 0.57 3.43
Toll-like Receptor Signaling related to MyD88%WikiPathways_20191210%WP3858%Homo sapiens -5.25 -4.82 1.46 0.45 -0.53 0.73 1.56 0.34 1.76 2.35 -0.98 0.46 0.45 0.52 3.51 1.03 -1.97 -3.3 -1.17 0.39 -1.81 0.05 4.29 3.47 -0.68 -2.32
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression%WikiPathways_20191210%WP3879%Homo sapiens 0.39 -0.2 -3.33 -3.66 2.63 2.17 0.43 0.68 0.69 2.35 -3.26 0.85 0.71 1.45 -0.22 0.01 -0.97 -1.87 2.87 0.19 -3.11 -1.95 1.19 1.92 -0.36 0.39
Ectoderm Differentiation%WikiPathways_20191210%WP2858%Homo sapiens 1.44 -0.38 8.93 18.75 -6.51 -7.26 -1.73 -0.63 -0.45 -3.12 5.1 -3.82 -4.46 -4.51 -0.16 0.09 1.4 3.21 -2.8 -2.51 6.31 2.99 -1.78 -6.57 -1.56 0.05
Physiological and Pathological Hypertrophy  of the Heart%WikiPathways_20191210%WP1528%Homo sapiens -1.18 0.06 -1.35 -4.25 2.56 3.08 1.26 -2.3 2.41 1.95 0.82 0.92 0.16 0.98 0.05 0.62 -3.13 -1.66 2 0.41 -3.86 -3.4 3.33 4.17 0.23 -3.89
Integrin-mediated Cell Adhesion%WikiPathways_20191210%WP185%Homo sapiens -3.91 -3.38 -4.8 -11.5 5.27 7.13 -0.24 -2.48 2.92 3.71 -3.07 1.64 3.52 4.62 0.23 0.75 -2.21 -4.59 2.59 2.27 -5.57 -1.93 5.29 7.09 -0.15 -3.19
Preimplantation Embryo%WikiPathways_20191210%WP3527%Homo sapiens -6.89 -3.93 -1.67 -7.57 4.56 5.38 -0.43 0.81 -0.85 2.52 -3.96 0.64 1.99 2.24 0.68 3.2 -2.84 -4.88 2.93 2.46 -6.41 -0.13 3.22 5.75 1.7 1.5
Dopaminergic Neurogenesis%WikiPathways_20191210%WP2855%Homo sapiens 3.61 1.05 3.06 8.1 -1.36 -3.51 -0.3 0.47 1.96 -0.95 3.33 -1.32 -1.51 -0.32 0.36 -1.33 0.67 1.25 -1.93 -2.29 3.23 -0.6 -0.61 -4.9 -2.89 -3.28
Human Complement System%WikiPathways_20191210%WP2806%Homo sapiens -10.16 -6.6 -1.23 -6.55 4.53 7.17 1.63 0.72 1.46 4.43 -3.14 0.74 5.8 5.69 3.53 2.29 -5.52 -7.87 -0.74 2.26 -6.99 0.22 4.5 6.99 -0.91 -2.24
Mammary gland development pathway - Puberty (Stage 2 of 4)%WikiPathways_20191210%WP2814%Homo sapiens 3.76 3.26 2.21 3.14 -0.1 -2.73 -1.37 -0.22 0.37 -1.57 3.02 -0.6 -2.24 -2.55 -1.64 -0.35 1.86 1.61 -0.05 -0.91 3.62 -0.69 -1.87 -4.24 -0.89 -0.84
Novel intracellular components of RIG-I-like receptor (RLR) pathway%WikiPathways_20191210%WP3865%Homo sapiens -7.21 -6.18 2.16 0.3 -0.54 2.6 0.9 -0.99 3.76 3.19 0.89 -0.13 1.86 2.55 2.11 1.71 -4.76 -6.57 -1.96 0.48 -3.31 -0.27 4.76 5.5 0.93 -1.78
Monoamine GPCRs%WikiPathways_20191210%WP58%Homo sapiens -3.48 -0.15 -2.11 -7.9 -2.17 2.55 1.39 1.03 0.54 1.48 -2.9 -0.43 2.08 3.18 0.44 1.29 -5.29 0.37 2.35 4.14 -2.61 0.93 0.76 3.41 1.16 -0.06
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway%WikiPathways_20191210%WP3670%Homo sapiens -3.65 -2.2 5.98 6.38 -0.93 -0.8 0.71 -0.54 0.96 -0.09 1.35 -1.33 -0.52 0.23 1.04 0.42 -2.22 -3.59 -2 0.33 -1.77 0.67 1.02 1.09 0.13 -0.67
Metapathway biotransformation Phase I and II%WikiPathways_20191210%WP702%Homo sapiens 12.11 9.12 4.67 11.65 -5.28 -8.83 -2.37 0.36 -2.2 -6.31 5.56 -0.95 -6.32 -6.81 -2.03 -2.38 4.47 8.62 1.24 -2.26 8.76 -1.06 -5.5 -9.56 -3.51 -1.19
Cell-type Dependent Selectivity of CCK2R Signaling%WikiPathways_20191210%WP3679%Homo sapiens -0.42 -0.13 4.84 6.79 -2.99 -2.44 -0.52 -0.62 -1.46 1.39 0.88 -0.34 -1.59 -1.73 0.64 -0.85 1.33 0.37 -2.32 -0.71 0.58 0 -0.89 -1.88 0.42 1.66
Energy Metabolism%WikiPathways_20191210%WP1541%Homo sapiens 1.81 1.72 -7.89 -10.61 3.58 3.48 1.4 -0.88 2.2 0.12 -3.76 0.55 2.54 2.4 -0.28 -0.79 -0.8 0.68 3.06 2.06 -2.34 -1.54 0.62 1.8 1.27 -0.41
Endoderm Differentiation%WikiPathways_20191210%WP2853%Homo sapiens -4.31 -1.42 -10.59 -18.55 6.76 7.75 0.95 -0.28 0.58 3.6 -8.32 1.75 5.12 5.51 1.08 0.17 -0.36 -2.97 4.1 5.03 -5.4 -1.88 3.56 6.63 1.13 0.35
Glycerophospholipid Biosynthetic Pathway%WikiPathways_20191210%WP2533%Homo sapiens 6.37 2.74 -1.8 -2.14 2.19 -1.3 0.25 2.07 -2.62 -1.23 2.79 -0.65 -3.32 -2.08 -0.84 0.77 1.19 2.39 0.49 -1.72 3.39 0.68 -2.98 -4.22 -1.03 0.61
Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex%WikiPathways_20191210%WP3657%Homo sapiens 0.47 -0.14 6.13 8.61 -1.44 -2.45 0.09 -1.56 0.72 -0.26 3.47 -0.18 -1.5 -0.95 -1.02 -0.97 -0.5 -0.57 -2.22 -0.79 -0.44 -1.04 1.03 -0.64 -1.8 -2.02
MAPK Cascade%WikiPathways_20191210%WP422%Homo sapiens 0.91 0.45 -2.84 -4.04 4.93 4.85 0.67 -2.65 2.27 1.83 -1.15 0.81 2.02 2.03 -0.52 0.42 -2.37 -2.09 3.23 0.69 -5.62 -4.1 0.96 2.75 -0.97 -2.47
Glycogen Synthesis and Degradation%WikiPathways_20191210%WP500%Homo sapiens 0.35 0.28 3.21 6.66 -4.21 -4.22 -1.36 2.31 -2.54 -1.52 0.83 -1.45 -2.68 -4.05 0.74 0.89 1.32 1.94 -3.19 -2.09 4.24 3.11 -2.38 -2.94 2.63 4.13
Fatty Acid Beta Oxidation%WikiPathways_20191210%WP143%Homo sapiens 6.34 5.11 -3.21 2.6 -0.87 -0.92 -0.22 0.33 -2.26 -1.77 -0.79 0.82 -2.33 -3.11 -1.04 -2.41 1.63 5.76 1.47 0.41 3.82 -1.07 -2.76 -3.58 -1.51 -0.45
MAPK Signaling Pathway%WikiPathways_20191210%WP382%Homo sapiens -8.67 -6.67 -6.75 -16.06 6.5 8.9 3.31 0.34 4.37 5.82 -5.02 4.31 6.36 6.94 1.91 2.11 -5.99 -7.19 3.86 4.3 -11.44 -5.59 6.37 11.12 -0.1 -3.03
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM%WikiPathways_20191210%WP3959%Homo sapiens 5.84 4.73 2.68 7.55 -2.88 -4.55 -2.84 0.28 -2.8 -3.85 4.83 -1.52 -3.87 -3.43 -1.21 0.77 2.48 6.63 1.41 -1.69 4.69 -0.45 -4.08 -5.3 -2.61 -0.79
Osteoblast Signaling%WikiPathways_20191210%WP322%Homo sapiens -2.69 -2.97 -0.84 -4.08 2.25 3.06 0.47 -0.34 -0.2 1.03 -2.46 -0.48 2.3 2.78 -0.25 0.29 -1.26 -3.21 0.75 0.91 -2.75 2.1 0.66 3.74 0.95 0.26
Prolactin Signaling Pathway%WikiPathways_20191210%WP2037%Homo sapiens -3.05 -1.77 -5.63 -9.46 4.58 6.29 2.04 -1.43 2.28 2.99 -3.37 2.38 3.38 3.51 1.23 0.34 -2.39 -3.23 3.26 1.85 -6.14 -2.72 2.74 5.44 -0.05 -3.06
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway%WikiPathways_20191210%WP4577%Homo sapiens 1.26 -0.41 7.7 9.05 0.15 -1.43 -1.43 -3.37 1.44 -0.2 5.07 -2.53 -1.34 -0.47 -2.48 1.2 -0.13 -0.93 0.48 -2.67 -0.28 -2.11 0.94 -1.41 -2.45 -3.64
Osteopontin Signaling%WikiPathways_20191210%WP1434%Homo sapiens -2.42 -1.12 1.55 -0.27 -1.97 0.48 0.47 -0.69 1.68 0.65 2.15 -0.07 1.32 1.02 1.6 0.41 -2.96 -2.48 -2.62 -0.69 -1.73 -0.03 2.95 2.82 0.79 -0.83
Cori Cycle%WikiPathways_20191210%WP1946%Homo sapiens -4.57 -3.26 1.04 -1.94 -2.1 0.85 1.52 0.56 0.18 0.21 -2.03 0.29 0.45 0.56 2.06 0.03 -1.66 -2.1 -2.18 2.48 0.32 0.39 0.86 2.79 2.86 2.38
Circadian rhythm related genes%WikiPathways_20191210%WP3594%Homo sapiens 7.91 4.86 6.27 11.54 -6.77 -9.41 -3.21 2.16 -6.28 -4.79 5.62 -1.64 -5.45 -6.3 -0.54 -0.71 6.12 8.12 -3.05 -5.22 10.67 4.54 -6.64 -10.6 -1.23 4.05
G13 Signaling Pathway%WikiPathways_20191210%WP524%Homo sapiens -3.08 -1.09 -3.38 -6.38 2.67 4.14 0.76 -2.21 2.29 2.37 -1.74 2.75 3.32 3.51 -0.45 -0.17 -2.56 -2.98 -0.16 1.04 -5.05 -2.74 4.25 3.95 1 -0.07
Cholesterol Biosynthesis Pathway%WikiPathways_20191210%WP197%Homo sapiens -2.95 -2.42 0.33 -0.97 -0.09 0.73 2.56 1.54 2.66 3.27 -0.48 -0.6 -0.29 -0.17 1.81 1.4 -1.33 -2.38 -1.63 -1.53 -3.5 -2.75 3.05 2.73 1.2 -0.18
Follicle Stimulating Hormone (FSH) signaling pathway%WikiPathways_20191210%WP2035%Homo sapiens -4.76 -3.71 -1.69 -4.04 0.88 2.8 0.74 -1.1 1.06 2.21 -2.77 -0.57 2.89 3.15 0.69 0.25 -1.75 -3.17 0.9 1.21 -2.71 0.16 2.83 4.83 1.32 0.35
Heart Development%WikiPathways_20191210%WP1591%Homo sapiens -3.67 -1.97 -4.16 -8.41 3.36 4.75 -0.65 -0.71 -1.19 2 -4.9 1.52 3.41 3.6 0.4 1.1 -1.28 -2.86 1.2 2.99 -3.86 0.43 1.86 4.97 0.94 1.14
Irinotecan Pathway%WikiPathways_20191210%WP229%Homo sapiens 3.41 2.35 0.22 1.71 -1.43 -2.03 -1.32 0.13 -1.76 -2.4 0.56 0.63 -2.63 -2.62 -0.86 -0.25 2.37 5.26 1.09 0.47 3.73 -0.38 -2.13 -2 -1.43 -0.7
Fluoropyrimidine Activity%WikiPathways_20191210%WP1601%Homo sapiens -3.43 -1.8 -3.95 -5.82 1.24 2.3 -0.95 0.54 0.22 1.35 -1.82 -0.01 2.47 2.19 2.98 1.59 -2.57 -3.82 1.82 2.52 -4.07 -0.32 2.21 3.61 1.42 2.09
Pathogenic Escherichia coli infection%WikiPathways_20191210%WP2272%Homo sapiens 2.96 1.95 5.82 6.87 -3.63 -4.15 -1.57 0.09 -0.83 -1.32 3.29 -1.47 -3.48 -3.38 -1.26 -0.02 0.5 2.93 -1.72 -2.68 3.21 1.92 -1.91 -2.83 -0.08 0.78
Serotonin and anxiety-related events%WikiPathways_20191210%WP3944%Homo sapiens -0.91 -1.66 -0.71 -5.74 1.36 2.2 0.45 -0.25 1.09 0.45 -0.22 1.17 0.45 1.24 0.82 0.82 -2.74 -0.18 1.54 1.77 -2.17 -1.01 2.02 2.97 -0.02 -2.72
Aryl Hydrocarbon Receptor Pathway%WikiPathways_20191210%WP2873%Homo sapiens -0.23 1.5 3.54 7.11 -5.39 -5.72 -0.88 2.31 -2.77 -2.02 1.06 -1.21 -2.51 -2.69 2.55 1.8 0.88 2.03 -3.64 -1.44 5.39 3.94 -2.46 -3.5 -0.24 2.59
PDGFR-beta pathway%WikiPathways_20191210%WP3972%Homo sapiens -0.13 1.7 4.47 6.45 -3.54 -3.82 -2.23 0.59 -2.13 -1.17 0.71 -2.13 -2.32 -2.61 0.73 0.26 -0.07 1.24 -2.03 -0.42 4.12 2.61 -1.27 -2.01 1.18 1.83
Folate Metabolism%WikiPathways_20191210%WP176%Homo sapiens -7.62 -5.15 -2.24 -7.77 3.64 6.38 1.32 -0.17 1.1 3.37 -2.3 0.11 4.41 3.87 1.37 1 -3.28 -5.28 -1.85 1.25 -5.16 0.48 4.03 5.47 2.21 0.8
Photodynamic therapy-induced unfolded protein response%WikiPathways_20191210%WP3613%Homo sapiens -5.84 -4.93 3.87 1.85 -0.64 0.62 1.74 -0.79 2.55 1 -0.71 0.08 2.18 1.72 0.94 0.81 -1.77 -3.55 -3.5 0.82 -2.65 0.73 3.14 3.87 -0.1 -1.44
Senescence and Autophagy in Cancer%WikiPathways_20191210%WP615%Homo sapiens -5.02 -2.76 -3.97 -9.13 4.1 5.99 2.77 -1.04 4.63 4.22 -2.24 0.85 3.98 4.03 -0.61 -0.47 -3.64 -5.35 0.62 3.4 -7.39 -4.06 5.01 6.99 0.27 -1.16
Kennedy pathway from Sphingolipids%WikiPathways_20191210%WP3933%Homo sapiens -2.62 -2.27 4.34 4.74 -2.66 -0.94 0.2 0.28 0.29 -0.36 1.6 -0.06 0.48 0.28 0.58 -0.85 -1.44 -1.25 -2.82 0.72 -0.75 0.02 0.21 1.16 1.35 -0.24
Dopamine metabolism%WikiPathways_20191210%WP2436%Homo sapiens -3.4 -2.33 3.94 2.88 0.03 -0.33 1.11 -0.68 2.42 0.57 1.39 -1.6 1 0.34 1.31 -0.3 -1.16 -3.42 -2.94 0.57 -1.33 -0.83 1.22 0.67 0.91 -0.05
Endometrial cancer%WikiPathways_20191210%WP4155%Homo sapiens -1.68 -1.72 -4.95 -7.48 4.66 5.91 1.54 -3.17 4.65 3.43 -2.15 2.21 4.14 3.98 -0.28 -0.33 -2.26 -3.88 2.83 1.49 -5.74 -3.81 4.13 4.96 -1.47 -5.01
BMP Signaling Pathway in Eyelid Development%WikiPathways_20191210%WP3927%Homo sapiens -0.16 -1.15 -3.49 -5.28 2.7 3.75 0.49 1.25 -0.96 0.88 -2.18 2.13 1.64 0.8 -0.76 -0.95 -0.1 -0.34 0.73 0.41 -1.83 -0.6 -0.31 1.76 1.05 0.49
MicroRNAs in cardiomyocyte hypertrophy%WikiPathways_20191210%WP1544%Homo sapiens 3.09 0.86 5.35 6.92 -3.39 -5.72 -1.69 2.37 -3.49 -3.02 3.6 -2.79 -2.73 -3.33 -0.24 -0.22 2.61 3.42 -3.33 -1.53 6.47 4.49 -5.52 -6.66 0.68 3.8
G1 to S cell cycle control%WikiPathways_20191210%WP45%Homo sapiens -4.26 -4.23 -5.09 -11.46 3.65 4.77 0.82 -0.67 1.68 3.11 -2.27 0.51 4.15 4.1 2.22 1.23 -3.07 -1.98 1 2.25 -4.12 1.03 2.77 3.06 0.66 0.13
Integrated Cancer Pathway%WikiPathways_20191210%WP1971%Homo sapiens -4.12 -4.25 0.25 -1.43 2.97 4.77 0.7 -3.23 1.55 3.59 0.06 -0.18 3.47 3.76 -0.28 -0.89 -3.47 -3.91 0.16 -0.2 -4.68 -1.36 5.29 4.1 0.23 -2.91
GPCRs, Other%WikiPathways_20191210%WP117%Homo sapiens 9.67 7.09 0.15 5.49 -4.08 -6.42 -1.8 -0.33 -1.01 -2.55 2.73 0.97 -4.58 -3.4 -1.77 -2.79 4.93 6.47 -0.45 -2.39 5.95 0.09 -4.04 -6.07 -2.36 0.53
AMP-activated Protein Kinase (AMPK) Signaling%WikiPathways_20191210%WP1403%Homo sapiens 5.93 2.51 5.82 10.19 -2.68 -3.48 -2.61 -1.67 -1.82 -3.07 6.24 -1.36 -3.39 -2.69 -1.47 0.13 0.91 1.85 -0.58 -3.25 3.07 0.81 -2.3 -4.8 -1.48 -0.82
Tamoxifen metabolism%WikiPathways_20191210%WP691%Homo sapiens -5.06 -3.58 -0.06 -1.98 1.99 3 2.26 0.07 0.16 3.05 -1.23 -0.06 1.77 3.5 0.22 0.6 -1.42 -4.88 -2.25 -0.23 -3.63 1.16 1.99 2.84 1.02 0.73
T-Cell Receptor and Co-stimulatory Signaling%WikiPathways_20191210%WP2583%Homo sapiens -3.59 -3.54 -3.71 -6.75 3.06 4.3 1.95 -0.77 0.96 1.75 -2.98 0.33 3.05 2.98 2.12 1.33 -2.5 -2.06 0.59 0.19 -2.04 -0.64 3.07 4.74 -0.25 -1.61
Target Of Rapamycin (TOR) Signaling%WikiPathways_20191210%WP1471%Homo sapiens 1.82 1.35 -3.45 -3.62 -1.77 -1.74 -1.56 1.74 -3.23 -2.51 -2.06 1.65 -1.27 -1.47 -0.62 -0.81 2.71 5.16 0.77 1.9 6.13 3.03 -3.78 -2.44 0.49 3.56
Prion disease pathway%WikiPathways_20191210%WP3995%Homo sapiens -2.4 -1.58 -4.96 -6.84 3.43 3.83 2.11 -1.23 2.58 1.56 -4.66 1.26 4.26 2.86 0.24 0.88 -0.54 -3.71 1.26 1.29 -3.24 -2.09 3.31 3.82 0.54 -1.95
Signaling Pathways in Glioblastoma%WikiPathways_20191210%WP2261%Homo sapiens 1.95 1.76 7.64 12.58 -4.4 -5.72 -1.83 0.7 -4.02 -2.98 5.43 -2.35 -4.1 -4.92 0.18 1.72 1.08 3.05 -1.98 -3.46 4.68 3.2 -4.06 -5.3 -0.46 1.62
Degradation pathway of sphingolipids, including diseases%WikiPathways_20191210%WP4153%Homo sapiens -0.12 1.74 -4.02 -4.41 2.09 1.17 -0.54 -0.67 0.46 -0.11 -2.25 1.93 0.46 -0.29 0.26 -0.93 3.02 1.57 1.09 0.29 -1.36 -0.65 -0.21 -0.25 0.97 0.76
Proteasome Degradation%WikiPathways_20191210%WP183%Homo sapiens -8.05 -5.01 6.69 3.33 -3.06 0 2.66 1.14 3.02 1.74 1.14 -2.71 1.02 1.4 2.84 2.32 -5.11 -7.08 -3.54 0.22 -3.99 0.83 4.08 3.91 2.72 -0.51
Inflammatory Response Pathway%WikiPathways_20191210%WP453%Homo sapiens 7.26 4.37 -0.13 3.18 -1.68 -3.76 -0.5 -0.27 -1.2 -1.29 1.65 -0.41 -3.8 -3.98 -1.87 -0.31 2.32 4.68 1.04 -1.06 3.79 0.44 -2.74 -4.89 -1.56 0.7
Association Between Physico-Chemical Features and Toxicity Associated Pathways%WikiPathways_20191210%WP3680%Homo sapiens -0.02 1.1 -6.68 -9.6 4.86 5.99 2.6 -2.05 1.79 2.32 -2.77 1.61 3.01 3.73 -0.1 -0.03 -2.36 -1.78 4.47 0.98 -5.79 -3.81 1.92 4.22 -0.3 -3.31
GPCRs, Class B Secretin-like%WikiPathways_20191210%WP334%Homo sapiens -4.29 -2.11 -0.59 -5.08 2.29 3.89 -1.27 0.34 0.62 -0.81 -1.74 0.19 2.49 2.08 1.01 -0.17 -1.18 -1.79 -0.38 0.87 -2.22 1.8 0.74 3.26 1.15 0.92
IL-9 Signaling Pathway%WikiPathways_20191210%WP22%Homo sapiens -1.3 -0.85 -1.98 -2.93 1.53 2.27 1.05 -0.99 1.98 2.45 -1.01 0.98 1.53 2.01 0.21 0.42 -0.04 -2.26 1.39 0 -4.65 -2.38 2.9 2.45 -0.31 -2.47
Oxidative Stress%WikiPathways_20191210%WP408%Homo sapiens 1.05 -0.44 -5.79 -3.76 4.41 4.62 0.3 -0.89 1.98 1.77 -0.92 1.35 1.96 2.42 -0.77 -0.75 0.53 -0.4 2.35 0.83 -4.15 -4.31 1.71 2.18 -1.83 -3.45
Endochondral Ossification%WikiPathways_20191210%WP474%Homo sapiens -3.25 -2.48 -3.83 -12.24 2.44 4.24 0.67 -0.38 -0.4 1.44 -3.53 0.18 3.04 2.8 0.76 1.78 0.64 -1.98 0.66 1.26 -0.2 1.35 1.02 3.12 1.85 1.03
Complement and Coagulation Cascades%WikiPathways_20191210%WP558%Homo sapiens 7.55 5.34 0.14 1.8 -2.67 -5.49 -2.69 -0.68 -1.52 -3.36 2.36 -0.03 -3.72 -3.99 -4.04 -0.94 4.53 7.31 0.61 -1.92 6.3 0.29 -3.77 -5.62 0.64 3.57
Cell Cycle%WikiPathways_20191210%WP179%Homo sapiens -5.92 -5.08 -4.76 -10.44 6.49 7.64 2.29 -1.81 4.34 4.94 -4.09 1.19 5.63 5.73 1.32 -0.31 -4.5 -6.36 0.52 2.35 -7.85 -1.88 5.71 6.76 1 -2.91
Endothelin Pathways%WikiPathways_20191210%WP2197%Homo sapiens -5.38 -4.25 -0.85 -4.91 0.39 2.36 0.96 0.39 2.85 1.93 -1.09 0.67 3.15 2.33 1.9 1.62 -2.87 -3.37 -1.85 0.19 -2.79 0.28 4.61 4.45 0.66 -1.39
Matrix Metalloproteinases%WikiPathways_20191210%WP129%Homo sapiens 3.5 2.82 2.84 5.26 -5.15 -4.72 -0.65 -0.48 -0.02 -3.32 1.52 -1.13 -1.92 -2.74 0.79 -2.02 1.77 5.18 -0.93 -1.75 5.47 1.76 -2 -3.07 -1.02 0
Oxidation by Cytochrome P450%WikiPathways_20191210%WP43%Homo sapiens 7.29 6.37 1.25 4.65 -5.17 -6.26 -0.34 0.17 -0.87 -4.85 3 -0.56 -3.58 -3.86 -0.15 -1.7 2.67 7.26 0.48 -1.32 6.26 0.67 -4.43 -5.52 -1.25 -0.21
Apoptosis%WikiPathways_20191210%WP254%Homo sapiens -6.82 -5.79 -3.76 -7.95 3 5.7 2.43 0.68 2.71 4.72 -4.44 1.25 5.55 4.97 2.31 0.12 -4.36 -5.27 -0.68 2.89 -5.25 -1.38 4.58 6.78 1.29 -3.28
Common Pathways Underlying Drug Addiction%WikiPathways_20191210%WP2636%Homo sapiens 2.04 1.59 0.68 4.66 -2.2 -3.29 -3.79 2.18 -4.1 -2.1 0.07 -0.94 -2.48 -2.94 -1.3 -0.19 4.73 4.22 -2.23 -1.51 5.73 4.79 -3.12 -5.18 0.74 3.94
IL-6 signaling pathway%WikiPathways_20191210%WP364%Homo sapiens -0.73 0.17 -4.45 -7.41 3.22 4.91 2.6 -1.62 3.39 2.83 -1.93 1.93 2.12 2.56 0.79 0.21 -2.85 -2.93 3.17 1.28 -6.55 -3.5 2.89 4.11 -0.89 -3.31
Nuclear Receptors%WikiPathways_20191210%WP170%Homo sapiens 2.85 2.59 5.05 9.33 -3.36 -4.2 0.23 -0.51 0.6 -0.48 2.49 -2.04 -1.93 -1.79 0.69 -1.48 -0.56 -0.08 -2.15 -1.9 3.22 0.97 -0.63 -3.46 -1.65 -1.81
Type II diabetes mellitus%WikiPathways_20191210%WP1584%Homo sapiens -4.98 -3.59 -0.9 -1.76 0.07 1.78 0.1 -0.97 0.35 1.07 -2.62 1.22 1.25 1.52 1.72 0.68 -2.16 -2.38 -0.93 1.42 -1.78 1.54 2.59 4.01 1.75 0.98
p38 MAPK Signaling Pathway%WikiPathways_20191210%WP400%Homo sapiens 5.88 3.17 -0.07 -0.33 -1.05 -3.15 0.16 0.48 -1.34 -2.71 -0.26 -0.67 -2.9 -3.47 -1.45 -1.21 3.75 4.29 -0.28 -0.53 6.09 1.27 -2.06 -4.46 -0.55 1.4
Iron metabolism in placenta%WikiPathways_20191210%WP2007%Homo sapiens -0.76 1.05 -1.67 -3.82 1.36 2.48 0.5 0.14 0.84 1.65 -2.64 0.82 1.35 -0.04 0.26 -1.23 -0.51 -2.89 1 1.37 -1.43 -2.25 1.57 3.1 0.68 -0.92
Aryl Hydrocarbon Receptor Netpath%WikiPathways_20191210%WP2586%Homo sapiens -0.17 -1.27 -3.62 -6.86 5.92 6.4 0.71 -2.1 2.01 1.14 -2.19 -0.37 3.65 3.49 -2.19 -2.12 -1.64 -2.52 2.4 2.13 -4.99 -2.78 2.89 4.04 0.37 -2.33
TNF alpha Signaling Pathway%WikiPathways_20191210%WP231%Homo sapiens 5.88 5.38 1.42 3.39 -3.24 -5.4 -1.92 1.76 -5.1 -4.95 -1.08 -1.03 -3.31 -3.93 -1.47 -1.12 4.56 6.17 -1.52 -1.28 8.47 3.69 -5.84 -6.4 1.28 5.59
Nucleotide Metabolism%WikiPathways_20191210%WP404%Homo sapiens -4.15 -1.73 3.91 0.64 -3.15 -1.07 0.54 1.37 -0.89 0.2 2.88 -0.95 0.17 -0.16 1.18 1.76 -2.54 -3.41 -0.72 -0.14 -1.17 2.28 0.34 2.15 2.15 0.53
Apoptosis Modulation and Signaling%WikiPathways_20191210%WP1772%Homo sapiens 6.31 6.36 2.52 5.3 -2.6 -5.27 -2.35 -1.07 -1.6 -4.46 4.21 -1.93 -4.93 -4.18 -3.15 -0.49 6 4.62 -0.05 -2.12 5.93 1.02 -3.89 -7.61 0.02 3.43
Differentiation of white and brown adipocyte   %WikiPathways_20191210%WP2895%Homo sapiens -3.53 -2.46 -3.78 -6.42 3.09 2.72 0.36 0.91 -0.69 1.56 -2.36 1.38 2.37 3.08 1.05 0.02 0.05 -2.53 0.74 1.81 -2.8 1.96 0.27 3.03 0.17 0.01
Drug Induction of Bile Acid Pathway%WikiPathways_20191210%WP2289%Homo sapiens -5.96 -4.28 -0.56 -4.83 2.67 3.27 0.09 -0.32 0.6 2.14 -1.27 0.9 2.44 3.25 0.25 0.71 -0.53 -5.18 0.29 -0.35 -3.38 1.43 3.06 3.21 1.39 0.93
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway%WikiPathways_20191210%WP2018%Homo sapiens -3.5 -2.64 -4.42 -7.85 5.74 6.26 1.75 -0.48 1.65 2.65 -2 1.38 2.06 4.07 -0.06 0.49 -0.78 -2.7 2.65 1.33 -5.57 -2.25 1.22 3.72 -0.51 -2.23
Wnt Signaling%WikiPathways_20191210%WP428%Homo sapiens -3.54 -1.34 -6.82 -16.24 3.89 7.02 1.23 1.67 -0.17 1.71 -6.1 2.77 3.19 3.22 1.83 1.2 -3.49 -2.23 2.48 4.04 -3.73 0.76 1.25 6.41 1.03 -0.03
Estrogen signaling pathway%WikiPathways_20191210%WP712%Homo sapiens -0.82 -0.86 -1.77 -0.8 3.32 3.98 -0.08 -2.68 2.4 1.1 0.46 1.48 2.06 1.63 -1.53 -1.6 -0.5 -1.63 1.67 0.14 -4.26 -4.46 2.19 3.6 -0.73 -2.32
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation%WikiPathways_20191210%WP314%Homo sapiens 4.23 4.02 0.89 3.6 0.26 -2.07 -3.99 -0.44 -3 -3.32 2.7 -0.62 -3.43 -2.93 -2.94 0.97 4.74 4.54 1.65 -0.1 3.91 0.97 -3.29 -5.38 -2.04 1.08
Hypertrophy Model%WikiPathways_20191210%WP516%Homo sapiens -3.96 -2.9 -0.28 -2.96 0.95 3.23 1.3 -0.7 0.28 0.44 -2.16 -0.47 2.53 2.41 1.79 -0.18 -2.82 -2.94 0.1 0.55 -2.08 0.72 2.61 3.84 0.88 -0.19
Hedgehog Signaling Pathway Netpath%WikiPathways_20191210%WP47%Homo sapiens -1 1.4 -3.88 -5.6 1.27 2.9 -0.12 -0.44 -1.11 0.98 -3.8 0.4 0.08 0.76 0.07 -0.22 -0.32 0.44 1.43 2.11 -1.83 -0.18 0.52 3.21 2.72 0.21
Cannabinoid receptor signaling%WikiPathways_20191210%WP3869%Homo sapiens -2.48 -1.97 -0.54 -4.01 2.94 3.02 1.9 -1.49 3.77 2.16 -1.33 -0.37 2.58 3.56 1.86 1.1 -3.69 -3.78 1.2 1.39 -5.91 -3.09 3.38 4.04 -0.35 -3.87
Retinoblastoma Gene in Cancer%WikiPathways_20191210%WP2446%Homo sapiens 7.6 5.08 1.89 6.39 -4.45 -6.2 -2.21 1.26 -4.09 -5.05 2.6 -0.13 -4.71 -4 -2.12 0.77 4.11 7.29 2.16 -1.43 7.54 1.5 -5.47 -6.93 -2.37 0.96
SREBF and miR33 in cholesterol and lipid homeostasis%WikiPathways_20191210%WP2011%Homo sapiens -4.35 -2.7 -4.81 -4.77 1.34 1.64 0.69 2.39 0.89 2.49 -2.58 -0.57 2.29 2.78 1.57 1.08 0 -0.89 -1.69 -1.05 -0.16 0.57 1.17 2.69 0.87 1.12
ACE Inhibitor Pathway%WikiPathways_20191210%WP554%Homo sapiens -2.8 -4.17 0.73 -1.72 2.09 3.1 -0.08 -0.45 0.89 2.13 -3.49 -0.51 3.27 1.55 0.98 0.69 -3.38 -3.56 -0.48 1.16 -4.14 1.11 2.36 3.02 1.77 -0.09
Cardiac Progenitor Differentiation%WikiPathways_20191210%WP2406%Homo sapiens -5.15 -2.52 -2.79 -8.23 3.43 5.69 -0.07 0.44 -0.06 1.64 -5.34 -0.36 2.68 3.38 1.09 0.42 -1.15 -3.6 1.43 2.75 -4.64 0.16 3.99 5.87 1.21 -0.27
Pathways Affected in Adenoid Cystic Carcinoma%WikiPathways_20191210%WP3651%Homo sapiens -2.71 -1.1 -8.5 -10 2.51 4.42 2.31 1.11 1.51 1.63 -6.79 1 4.22 3.36 1.35 0.3 -1.74 -1.79 0.85 2.18 -2.66 -1.59 1.97 4.93 2.6 0.63
miRNA regulation of prostate cancer signaling pathways%WikiPathways_20191210%WP3981%Homo sapiens 0.66 -0.48 4.07 3.73 -2.75 -4.11 -0.8 2.35 -2 -2.07 1.26 -1.22 -2.62 -2.79 1.11 0.6 2.73 1.82 -3.64 -1.96 4.35 3.61 -2.1 -3.65 0.74 3.19
Human Thyroid Stimulating Hormone (TSH) signaling pathway%WikiPathways_20191210%WP2032%Homo sapiens -2.57 -2.49 -4.62 -8.83 4.49 5.47 1.91 -2.92 3.59 3.28 -3.19 1.26 3.93 4.94 -0.97 -1.19 -1.54 -3.37 1.54 2.39 -4.86 -3.35 3.95 5.88 -0.2 -2.52
Cardiac Hypertrophic Response%WikiPathways_20191210%WP2795%Homo sapiens -1.6 -0.86 -2.62 -4.09 1.35 4.06 1.55 -0.33 2.32 3.13 -3.04 2.61 1.13 2.6 0.41 -0.52 -2.54 -2.63 4.19 2.11 -6.1 -4.71 4.38 6.1 -2.32 -4.59
Canonical and Non-Canonical TGF-B signaling%WikiPathways_20191210%WP3874%Homo sapiens -4.41 -1.87 1.47 -3.54 0.88 2.16 1.24 -1.55 2.24 1.47 -0.46 -1.23 1.09 2.69 1.23 0.73 -2.62 -2.4 -0.09 -0.03 -2.62 -1.09 3.11 4.4 1.34 -2.13
EPO Receptor Signaling%WikiPathways_20191210%WP581%Homo sapiens -0.18 -0.43 -3.21 -5.12 1.15 2.73 1.83 -0.71 0.65 1.07 -2.38 1.01 1.12 1.1 1.09 1.06 -1.01 -2.24 3.86 0.61 -3.9 -1.35 2.22 3.59 -0.42 -2.15
Apoptosis-related network due to altered Notch3 in ovarian cancer%WikiPathways_20191210%WP2864%Homo sapiens 2 3.04 2.76 6.14 -5.04 -4.92 -2.17 0.79 -4.34 -3.49 0.93 -0.9 -2.28 -2.69 0.03 0.38 1.8 5.09 -1.6 -1.42 5.08 5.28 -4.34 -4.79 1.4 3.29
Parkin-Ubiquitin Proteasomal System pathway%WikiPathways_20191210%WP2359%Homo sapiens 5.55 4.99 -1.7 0.82 -0.94 -2.86 -2.45 0.15 -5.36 -4.13 0.53 -0.11 -2.64 -3.43 -2.36 -0.97 5.85 7.29 1.53 -1.95 6.8 4.83 -4.7 -5.72 -1.44 2.41
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway%WikiPathways_20191210%WP2380%Homo sapiens -2.73 -2.43 -5.84 -12.81 6.49 9.18 3.29 -2.86 6.37 4.48 -3.39 1.26 5.23 6.3 -0.25 -0.35 -4.17 -6.49 3.93 2.62 -9.24 -5.7 5.73 6.98 -0.37 -5.25
Triacylglyceride Synthesis%WikiPathways_20191210%WP325%Homo sapiens -4.54 -3.63 -0.04 -3.44 3.01 2.82 0.25 -1.53 3.23 3.12 -1.1 0.3 2.5 2.71 0.53 1.67 -1.16 -4.99 0.66 0.29 -5.52 -1.64 2.61 3.03 0.35 0.49
Ebola Virus Pathway on Host%WikiPathways_20191210%WP4217%Homo sapiens -6.11 -4.05 -5.75 -12.07 6.48 6.55 1.11 -2.26 4.58 4.59 -2.22 3.89 4.33 4.54 -0.03 0.2 -2.02 -6.75 0.53 1.49 -6.81 -3.06 5.5 6.41 2.33 -1.37
Osteoclast Signaling%WikiPathways_20191210%WP12%Homo sapiens 6.09 4.17 -0.22 3.8 -0.08 0.27 -0.49 -0.98 -0.16 -1.57 0.06 -1.41 -1.59 -1.54 -2.5 -1.94 1.9 2.78 1.77 -1.32 0.64 -2.26 -0.12 -2.86 -1.52 -0.89
Microglia Pathogen Phagocytosis Pathway%WikiPathways_20191210%WP3937%Homo sapiens -1.69 -1.08 -5.2 -6.36 -0.84 0.73 3.09 1.1 -0.42 2.15 2 4.96 1.37 1.51 1.55 -0.54 1.14 -0.17 3.52 3.36 -2.49 -2.48 2.3 2.89 -3.87 -6.52
Peptide GPCRs%WikiPathways_20191210%WP24%Homo sapiens -9.94 -7.04 -1 -6.33 4.04 6.29 0.61 0.18 0.3 2.69 -4.64 0.27 3.81 3.84 2.13 3.6 -4.13 -6.22 1.17 2.95 -5.1 0.78 3.08 5.58 1.26 1.83
Nucleotide-binding Oligomerization Domain (NOD) pathway%WikiPathways_20191210%WP1433%Homo sapiens 6.07 6.66 -0.62 2.72 -1.98 -3.33 0.15 -0.18 -0.17 -3.1 0.11 -1.78 -2.54 -1.73 -0.88 -0.59 2.18 4.54 1.07 0.05 4.4 1.04 -4.01 -5.37 -1.25 -1.46
Wnt Signaling in Kidney Disease%WikiPathways_20191210%WP4150%Homo sapiens -2.72 0.41 -4.17 -7.43 1.21 3.58 0.03 3.18 -3.12 1.26 -5.83 2.78 0.31 -0.58 0.3 0 -0.59 -0.19 1.8 1.85 -0.24 2.56 -0.72 3.05 0.74 2.54
Androgen receptor signaling pathway%WikiPathways_20191210%WP138%Homo sapiens 3.63 2.98 -10.01 -11.31 5.12 6.86 2.47 -0.62 0.83 -0.08 -5.91 0.43 3.03 2.74 -2.21 -2.68 0.35 2.3 4.09 3.92 -2.17 -1.96 -1.67 0.84 -0.21 -0.74
LTF danger signal response pathway%WikiPathways_20191210%WP4478%Homo sapiens -3.92 -3.37 -1.29 -3.59 0.9 2.36 2.64 1.59 0.1 0.68 -2.28 0.4 1.78 0.71 2.03 0.3 -2.28 -2.16 -0.13 0.51 -1.14 0.48 2.26 3.96 0.05 -0.56
Splicing factor NOVA regulated synaptic proteins%WikiPathways_20191210%WP4148%Homo sapiens -1.86 -1.08 -3.21 -11.04 3.03 4.66 2.4 0.14 1.88 1.59 -1.91 -0.17 3.2 2.75 2.34 1.24 -4.37 -3.88 1.59 2.03 -2.44 -1.26 2.46 4.17 0.95 -3.21
NAD+ biosynthetic pathways%WikiPathways_20191210%WP3645%Homo sapiens -4.75 -3.74 0.78 -2.99 1.54 2.78 1.42 -0.22 2.42 1.18 -2.6 -0.21 2.05 1.22 1.34 0.48 -3.14 -3.81 -1.44 1 -2.86 0.67 1.62 3.8 2.85 0.61
Biogenic Amine Synthesis%WikiPathways_20191210%WP550%Homo sapiens 4.83 3.56 0.2 2.86 -1.4 -2.26 -1.36 -0.33 -0.54 -2.53 0.31 0.38 -1.07 -2.25 1.08 -1.6 0.7 2.47 0.32 -2.63 3.04 0.99 -1.11 -3.07 -0.42 -0.18
Hedgehog Signaling Pathway%WikiPathways_20191210%WP4249%Homo sapiens -4.84 -3.08 -4.6 -8.63 3.03 3.94 1.62 -0.09 2.21 2.3 -3.61 1.13 2.89 3.36 1.1 -0.38 -0.98 -2.89 0.03 1.76 -3.3 0.39 2.57 4.86 1.98 -0.78
Photodynamic therapy-induced HIF-1 survival signaling%WikiPathways_20191210%WP3614%Homo sapiens -4.49 -1.87 -0.74 -3.87 1.41 3.45 1.78 1.22 3.23 2.82 -3 0.18 3.29 3.34 1.11 -0.82 -3 -2.85 -1.26 1.8 -3.88 -3.04 2.46 4.11 0.49 -1.86
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling%WikiPathways_20191210%WP3612%Homo sapiens -1.11 -0.73 4.79 5.41 -3.71 -3.1 1.03 1.31 -1.39 -0.45 -0.68 -1.81 -1.25 -1.53 1.02 0.58 -0.68 -2.1 -3.62 -1.36 3.98 3.44 -0.94 -1.76 1.82 2.82
Trans-sulfuration and one carbon metabolism%WikiPathways_20191210%WP2525%Homo sapiens 2.02 2.24 2.72 9.55 -2.52 -3.31 -0.76 -0.54 -0.66 -1.22 1.42 -0.65 -3.37 -2.43 -0.28 -0.43 1.36 3.62 -0.24 -1.76 3.54 1.04 -2.61 -3.24 -2.07 -1.41
Cytokines and Inflammatory Response%WikiPathways_20191210%WP530%Homo sapiens -8.6 -4.81 0.62 -4.12 0.85 3.79 1.72 0.79 1.11 2.26 -0.42 -0.35 2.78 2.21 1.75 1.13 -2.69 -4.6 -1.2 0.12 -3.88 0.18 3.19 4.96 2.1 1.1
Homologous recombination%WikiPathways_20191210%WP186%Homo sapiens -4.25 -2.92 0.38 -2.42 0.68 0.76 0.83 0.65 0.08 1.6 -0.77 0.21 1.79 2.52 0.05 1.11 -1.63 -4.34 -0.07 0.27 -1.64 0.67 1.62 2.78 1.11 0.91
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease%WikiPathways_20191210%WP3668%Homo sapiens -5.24 -3.91 2.26 -0.7 -1.16 1.55 0.87 -0.47 1.41 1.84 -1.38 0.52 0.67 1.47 1.33 1.16 -3.94 -2.77 0.02 1.17 -1.95 0.06 2.33 5.18 1.18 -1.51
Ethanol effects on histone modifications%WikiPathways_20191210%WP3996%Homo sapiens -5.04 -4.5 1.64 0.91 3.11 3.73 0.09 0.12 1.25 2.34 -0.84 0.48 1.76 2.03 0.23 0.63 -1.73 -4.56 0.34 1.94 -4.37 -1.42 2.46 3.04 -1.56 -2.08
ErbB Signaling Pathway%WikiPathways_20191210%WP673%Homo sapiens -3.19 -1.65 -6.04 -10.21 5.17 7.15 2.89 -1.82 4.39 3.2 -3.16 1.91 4.88 5.55 0.63 -0.78 -3.41 -4.28 2.86 1.85 -7.4 -4.71 4.72 6.17 -0.48 -4.27
Interleukin-11 Signaling Pathway%WikiPathways_20191210%WP2332%Homo sapiens -1.61 -0.59 -4.56 -6.08 3.73 4.4 -0.29 -3.19 2.93 3.37 -2.4 1.66 2.71 2.82 -0.43 -0.42 0.15 -3.59 2.64 0.14 -4.44 -2.64 3.37 4.64 -0.61 -1.7
Fatty Acid Omega Oxidation%WikiPathways_20191210%WP206%Homo sapiens 2.68 2.4 0.34 3.76 -1.41 -3.4 -1 -0.91 -0.76 -1.34 3.03 0.38 -0.56 -1.74 -2.08 -0.84 1.4 3.66 -0.2 -1.44 3.62 -0.17 -2.24 -2.58 -1.3 0.71
Vitamin D Receptor Pathway%WikiPathways_20191210%WP2877%Homo sapiens 11.52 9.8 2.76 10.6 -7.26 -9.51 -0.72 -1.07 -0.54 -5.85 4.77 -0.86 -5.63 -6.79 -2.34 -2.51 5 11.13 0.42 -3.99 10.16 0.5 -5.28 -10.25 -2.68 -1.39
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway%WikiPathways_20191210%WP3932%Homo sapiens 10.14 7.21 7.13 14.9 -7.56 -11.17 -1.46 0.7 -4.32 -6.74 6.27 -2.93 -8.57 -9.49 1.66 -1.2 5.31 10.92 -3.32 -6.16 12.87 4.59 -6.37 -11.96 -1.41 0.97
IL-4 Signaling Pathway%WikiPathways_20191210%WP395%Homo sapiens -3.29 -1.17 -3.69 -4.98 5.32 4.7 1.21 -2.14 4.33 3.02 -1.03 1.83 3.35 4.17 -0.12 0.61 -0.1 -4.25 3.41 0.2 -6.45 -5.24 3.46 3.53 -1.94 -4.74
Wnt Signaling Pathway (Netpath)%WikiPathways_20191210%WP363%Homo sapiens -2.37 -1.29 -7.58 -11.21 2.52 3.55 2.17 1.79 0.97 1.13 -5.57 1.25 2.97 3.87 1.28 -0.1 -0.83 -0.25 1.21 2.55 -0.88 0.09 0.84 3.79 0.18 -0.06
IL-3 Signaling Pathway%WikiPathways_20191210%WP286%Homo sapiens -3.49 -1.54 -3.98 -8.54 1.73 4.16 3.17 -0.09 2.52 2.26 -2.55 1.91 2.45 3.1 0.76 -0.5 -0.65 -2.95 1.33 1.85 -4.6 -2.61 3.59 4.85 1.11 -3.28
Cell Differentiation - Index expanded%WikiPathways_20191210%WP2023%Homo sapiens 2.84 2.13 4.34 6.71 0.08 -2.43 0.25 -1.23 0.61 -1.51 3.8 -1.82 -1.86 -2.18 -0.38 -0.3 0.98 1.28 -0.96 -2.41 0.9 0.2 -0.65 -4 -2.69 -1.7
Monoamine Transport%WikiPathways_20191210%WP727%Homo sapiens 3.78 2.5 0.02 5.94 -2.24 -3.06 -0.21 -1.17 0.61 -2.64 2.04 -1.5 -2.14 -2.41 1.65 -0.83 1.81 3.47 -2.56 -2.25 3.56 -0.36 -0.93 -4.84 -0.3 2.07
T-Cell antigen Receptor (TCR)  Signaling Pathway%WikiPathways_20191210%WP69%Homo sapiens -8.15 -6.13 -4.09 -7.49 3.63 5.92 2.48 0 2.54 2.42 -3.18 1.91 5.04 4.47 3.57 -0.16 -3.54 -6.32 1.87 1.91 -7.79 -1.97 4.29 8.29 1.06 -0.55
One carbon metabolism and related pathways%WikiPathways_20191210%WP3940%Homo sapiens -3.22 -2.91 -5.46 -9.63 2.99 4.38 1.4 -1.26 2.06 3.46 -3.26 0.49 2.8 2.08 0.41 1.34 -3.26 -3.22 1.19 1.52 -2.69 -0.71 3.77 4.72 1.21 1.82
Small Ligand GPCRs%WikiPathways_20191210%WP247%Homo sapiens -4.11 -3.74 -0.76 -4.04 3.08 3.94 0.01 0.63 1.13 1.73 -2.06 1.07 1.91 1.52 1.04 0.61 -2.8 -4.04 -1.3 2.63 -4.25 -0.48 2.1 4.35 0.26 1.58
VEGFA-VEGFR2 Signaling%WikiPathways_20191210%WP3888%Homo sapiens -11.84 -6.9 -5.71 -14.81 10.18 11.98 4.79 -3.78 9.22 8.56 -3.85 3.43 8.91 8.98 1.69 0.57 -7.93 -11.65 0.4 3.44 -14.6 -7.8 11.01 12.78 -0.47 -6.6
Ganglio Sphingolipid Metabolism%WikiPathways_20191210%WP1423%Homo sapiens -1.7 -0.7 1.73 7.36 -2.33 -2.02 -0.4 0.38 -0.11 -0.6 0.2 -0.85 -0.28 -1.13 0.56 0.82 0.15 -0.34 -1.78 -0.39 0.38 1.64 0.24 0.31 0.01 -1.13
LncRNA involvement in canonical Wnt signaling and colorectal cancer%WikiPathways_20191210%WP4258%Homo sapiens -4.27 -1.38 -6.32 -13.49 2.69 6.37 0.8 2.11 -0.78 2.09 -6.39 3.12 3.19 2.98 1.64 -0.15 -2.25 -2.7 1.71 3.3 -3.47 1.58 0.57 6.07 1.31 1.66
Pancreatic adenocarcinoma pathway%WikiPathways_20191210%WP4263%Homo sapiens -5.28 -3.05 -5.56 -11.73 4.38 4.96 1.33 -2.86 4.66 3.32 -2.58 2.03 5.47 5.76 0.13 -0.17 -1.13 -3.63 2.49 1.63 -5.51 -2.56 4.78 6.02 -0.14 -2.75
Cells and Molecules involved in local acute inflammatory response %WikiPathways_20191210%WP4493%Homo sapiens -4.41 -3.87 1.28 -1.75 0.87 2.95 1.55 0.91 1.13 0.56 -2.31 -1.19 1.74 1.3 2.77 0.89 -3.25 -3.94 -2.23 0.52 -1.92 1.7 2.29 3.36 0.87 0.18
Ciliary landscape%WikiPathways_20191210%WP4352%Homo sapiens -9.68 -8.21 13.77 11.81 -2.9 -0.65 0.73 -2.25 4.17 4.39 5.61 -2.08 0.91 0.78 3.19 3.82 -8.05 -11.08 -3.82 -1.37 -8.26 -1.35 7.24 6.82 0.77 -4.29
Extracellular vesicles in the crosstalk of cardiac cells%WikiPathways_20191210%WP4300%Homo sapiens 4.09 2.91 -0.6 5.45 -1.58 -2.31 -1.46 -0.46 -1.43 0.87 2.65 1.14 -1.8 -1.34 -0.13 -0.14 0.93 2.06 1.79 -0.52 -0.02 -2.25 -1.61 -1.84 -2.88 -1.54
PI3K-Akt Signaling Pathway%WikiPathways_20191210%WP4172%Homo sapiens -12.84 -9.1 -5.68 -15.97 7.89 11.74 1.67 -0.14 3.95 7.24 -5.98 2.57 9.01 9.66 -1.51 1.18 -5.65 -11.9 1.43 5.04 -13.28 -2.56 7.97 12.55 2.52 0.18
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells%WikiPathways_20191210%WP4301%Homo sapiens -1.58 0.09 1.59 -0.68 -2.84 -3.1 -0.28 2.13 -1.63 -1.82 -0.47 0.27 -1.86 -2.03 -0.56 -1.16 2.88 2.32 -2.05 1.76 4.45 3.57 -1.37 -1 1.05 2.31
Non-small cell lung cancer%WikiPathways_20191210%WP4255%Homo sapiens 2.21 2.04 6.64 11.36 -3.85 -6.07 -1.12 0.93 -3.03 -3.28 3.28 -2.41 -4.44 -4.08 -0.53 0.36 2.29 1.49 -3.34 -2.31 5.97 2.16 -3.58 -5.12 0.78 3.65
Breast cancer pathway%WikiPathways_20191210%WP4262%Homo sapiens 5.39 3.68 8.54 15.55 -6.08 -9.41 -2.1 0.43 -2.42 -4.02 6.45 -4.36 -5.51 -5.11 0.33 0.29 2.29 5.28 -4.69 -3.57 7.53 2.53 -3.97 -8.6 -0.25 1.78
Metabolic reprogramming in colon cancer%WikiPathways_20191210%WP4290%Homo sapiens -7.11 -3.93 0.82 -5.16 -1.42 -0.56 1.05 3.06 0.58 1.82 -2.68 -0.42 2.16 1.92 2.45 1.38 -2.28 -4.19 -2.56 1.3 0.16 3.19 0.93 2.36 2.7 4.45
Methionine metabolism leading to Sulphur Amino Acids and related disorders%WikiPathways_20191210%WP4292%Homo sapiens -4.02 -2.52 4.84 1.13 -1.7 -0.9 0.98 -0.92 0.66 0.61 0.9 -0.9 0.56 -0.21 0.54 1.65 -2.47 -1.32 -1.65 0.27 -1.89 -0.34 2.79 3.24 1.33 -0.67
Fibrin Complement Receptor 3 Signaling Pathway%WikiPathways_20191210%WP4136%Homo sapiens -7.25 -4.81 -0.48 -2.5 2.57 4.6 1.49 -0.56 1.66 1.62 -4.03 -0.57 2.44 1.97 2.89 0.71 -3.24 -3.64 -2.43 0.78 -2.9 1.48 3.04 5.94 1.02 0.2
Resistin as a regulator of inflammation%WikiPathways_20191210%WP4481%Homo sapiens 4.69 2.33 1.95 6.03 -1.72 -4.39 -1.28 0.09 -2.11 -0.99 1.75 -1.8 -1.57 -2.15 -0.87 -0.61 2.47 2.9 -0.68 -1.49 2.8 1.64 -3.01 -4.84 -0.31 1.16
Thermogenesis%WikiPathways_20191210%WP4321%Homo sapiens 5.99 3.52 9.93 15.58 -3.84 -4.1 -1.86 -2.5 -0.85 -1.5 5.27 -1.95 -4.95 -5.66 -1.39 -1.56 1.03 1.81 -1.57 -3.47 2.86 -0.3 -1.47 -4.09 -2.42 -2.52
Metabolic pathway of LDL, HDL and TG, including diseases%WikiPathways_20191210%WP4522%Homo sapiens 3.66 1.7 0.02 6.81 -1.18 -2.19 -0.11 0.15 -0.87 -0.61 2.43 -0.59 -1.65 -1.61 -0.59 -0.47 2.59 1.64 -0.99 -1.46 1 -1.26 -1.45 -3.3 -1.37 -0.32
The human immune response to tuberculosis%WikiPathways_20191210%WP4197%Homo sapiens -1.57 -0.47 -3.49 -5.94 1.77 1.83 1.22 0.26 1.96 1.96 -3.46 -0.06 2.01 1.6 2.26 0.8 -2.19 -3.09 0.98 1.7 -1.6 -0.14 1.57 2.79 -0.27 -0.45
The alternative pathway of fetal androgen synthesis%WikiPathways_20191210%WP4524%Homo sapiens -3.38 -1.44 2.32 1.06 -0.28 -0.09 -0.15 0.37 1.36 1.23 -0.58 -1.07 0.24 -0.14 0.79 -0.43 -3.03 -3.4 -1.59 -0.23 -0.38 2.12 1.63 2.29 1.43 1.37
MET in type 1 papillary renal cell carcinoma%WikiPathways_20191210%WP4205%Homo sapiens 2.13 0.37 5 6.3 -4.24 -5.34 -1.8 1.99 -4.12 -3.19 2.52 -2.34 -3.41 -4.01 0.22 1.54 1.68 3.88 -2.11 -1.69 6.55 4.52 -3.4 -4.64 0.61 3
Hereditary leiomyomatosis and renal cell carcinoma pathway%WikiPathways_20191210%WP4206%Homo sapiens 0.76 0.69 -0.16 1.13 -2.97 -2.75 -1.21 1.35 -2.75 -2.06 1.26 0.1 -1.17 -1.49 -0.03 1.33 2.67 3.97 -1.19 -0.58 4.45 2.85 -2.32 -2.84 -0.13 1.06
Tryptophan catabolism leading to NAD+ production%WikiPathways_20191210%WP4210%Homo sapiens -4.41 -2.32 -1.93 -2.38 0.44 2.9 1.77 -0.05 1.17 1.24 -1.69 0.7 2.38 2.45 2.06 0.19 -2.59 -2.29 -1.18 0.51 -2.73 0.43 1.06 1.88 1.98 0.41
Transcriptional cascade regulating adipogenesis%WikiPathways_20191210%WP4211%Homo sapiens 0.91 0.59 -3.36 -2.22 1.89 2.49 1.38 1.02 1.1 1.39 -0.94 0.52 1.6 2.3 -0.08 -0.2 -2.67 -0.77 2.67 1.51 -3.1 -3.8 0.66 0.08 -1.21 -1.74
Oxysterols derived from cholesterol%WikiPathways_20191210%WP4545%Homo sapiens -4.09 -1.6 -1.71 -6.19 1.33 3.16 1.73 1.46 0.4 0.85 -3.15 1.05 1.34 0.72 0.68 -0.55 -0.81 -3.2 0.01 1.26 -2.05 0.14 1.54 4.71 1.33 1.67
MTHFR deficiency%WikiPathways_20191210%WP4288%Homo sapiens -4.74 -3.48 2.68 3.5 -3.02 -1.32 1.52 -0.59 1.24 0.94 -0.64 0 2.28 0.56 1.84 0.51 -2.8 -3.65 -1.07 1.24 0.01 0.81 0.99 3.28 0.12 -0.2
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome%WikiPathways_20191210%WP4320%Homo sapiens 2.91 1.8 4.22 5.1 0.31 0.19 -1.07 -3.05 -0.32 -1.36 3.06 -1.05 -0.52 -0.52 -0.9 -0.13 -1.31 1.43 2.04 -1.81 -2.93 -1.98 0.86 -0.72 -1.78 -2.48
Chromosomal and microsatellite instability in colorectal cancer %WikiPathways_20191210%WP4216%Homo sapiens 5.72 3.81 -0.33 3.01 -2.15 -3.11 -0.38 4.18 -4.43 -4.51 -1.76 -1.43 -3.5 -4.15 -2.15 -1.62 4.68 4.47 0.29 0.58 5.55 3.2 -5.29 -6.44 0.46 5.29
Rett syndrome causing genes%WikiPathways_20191210%WP4312%Homo sapiens 2.2 0.77 7.93 12.27 -3.63 -4.06 -2.72 -1.17 -2.51 -1.54 4.31 -1.13 -2.73 -3.45 -1.91 0.2 1.97 2.36 -1.79 -2.63 2.74 0.37 -2.29 -4.35 -0.62 1.39
Genotoxicity pathway%WikiPathways_20191210%WP4286%Homo sapiens 5.87 3.64 1.43 3.87 -2.92 -3.59 -0.74 1.38 -3.07 -3.86 0.95 -1.69 -2.93 -4.14 0.28 1.47 2.59 4.3 0.7 -0.83 6.12 3.41 -5.15 -5.67 -1.96 0.53
NRF2-ARE regulation%WikiPathways_20191210%WP4357%Homo sapiens -0.48 -0.61 3.98 4.27 -3.42 -3.54 -0.1 3.28 -2.67 -1.59 0.57 0.17 -3.49 -3.04 1.28 0.55 0.46 -0.12 -2.28 -0.47 3.81 3.17 -1.77 -1.87 1.4 2.5
Lipid Metabolism Pathway%WikiPathways_20191210%WP3965%Homo sapiens -0.6 -0.6 2.43 3.88 -2.28 -2.93 -1.84 1.32 -2.88 -2.57 2.69 -0.87 -1.55 -1.62 -0.37 0.36 1.87 0.74 -2.54 -0.89 5.36 4.78 -1.34 -2.6 0.6 1.44
Phosphodiesterases in neuronal function%WikiPathways_20191210%WP4222%Homo sapiens 5.45 3.77 1.78 11.96 -2.77 -4.43 -2.02 -0.6 -1.74 -2.17 2.66 -2.07 -2.62 -3.52 -1.36 -2.29 4.26 2.97 -2.93 -4.6 4.28 1.31 -2.17 -5.05 0.25 1.67
Ras Signaling%WikiPathways_20191210%WP4223%Homo sapiens 8.32 3.82 7.57 16.4 -4.79 -8.44 -2.84 0.1 -4.67 -3.99 5.66 -3.02 -6.63 -5.55 -2.03 0.71 3.41 5.61 -0.4 -2.46 6.68 2.35 -6.76 -9.65 -1.07 1.69
Pyrimidine metabolism and related diseases%WikiPathways_20191210%WP4225%Homo sapiens -1.79 -1.28 -2.17 -3.35 2.12 1.52 1.29 0.46 1.42 2.23 -1.43 -0.23 0.75 1.14 0.49 0.89 -0.9 -3.93 -1.43 -0.48 -1.94 -0.77 1.5 2.49 1.57 1.88
Purine metabolism%WikiPathways_20191210%WP4224%Homo sapiens -4.98 -3.37 -1.07 -2.49 0.28 2.81 2.02 -0.16 -0.26 1.98 -2.17 0.31 1.61 2.27 1.06 1.34 -1.58 -2.84 1 2.35 -4.12 -0.6 2.28 2.79 0.51 1.02
Ferroptosis%WikiPathways_20191210%WP4313%Homo sapiens -0.45 -1.09 3.46 5.72 -3.57 -3.98 -1.94 0.22 -2.57 -2.72 2.34 -0.67 -3.82 -2.88 0.99 1.75 2.91 3.25 -2.28 -0.95 5.13 4.65 -2.21 -2.65 0.44 0.91
Epithelial to mesenchymal transition in colorectal cancer%WikiPathways_20191210%WP4239%Homo sapiens 8.9 5.82 5.85 12.43 -4.08 -7.37 -0.79 -0.7 -1.34 -4.67 7.47 -3.1 -4.73 -3.33 -1.42 -1 2.16 7.3 -0.46 -4.74 5.51 0.71 -5.33 -10.8 -1.76 -0.55
Type 2 papillary renal cell carcinoma%WikiPathways_20191210%WP4241%Homo sapiens 0.58 1 -5.63 -8.77 1.13 2.82 1.36 0.68 0.06 -1.67 -4.34 -1.16 1.99 2.46 -1.56 -0.28 1.73 1.64 3.43 2.43 0.17 0.19 -0.72 1.28 0.95 0.25
Regulation of sister chromatid separation at the metaphase-anaphase transition%WikiPathways_20191210%WP4240%Homo sapiens -3.94 -3.04 -1.27 -0.98 1.93 2.06 0.14 -0.26 2.12 2.42 -1.92 0.6 2.36 2.47 1.26 0.99 -1.5 -4.35 -1.26 -0.54 -3.51 0.2 3.36 3.38 0.31 -1.04
Vitamin D in inflammatory diseases%WikiPathways_20191210%WP4482%Homo sapiens -0.92 -1.22 -0.32 -0.8 2.03 2.42 0.94 -0.47 2.66 2.11 0.84 0.78 0.59 1.02 -0.43 0.34 -2.25 -3.73 1.92 0.31 -4.24 -2.18 2.76 2.41 -1.78 -2.78
Oligodendrocyte Specification and differentiation(including remyelination), leading to Myelin Components for CNS%WikiPathways_20191210%WP4304%Homo sapiens -2.74 -1.69 -3.71 -7.43 3.92 3.27 -0.13 2.24 0.48 2.53 -1.05 1.19 0.9 0.01 0.44 -0.84 1.86 -4.34 -0.32 2.81 -2.39 -1.83 1.39 2.96 0.4 2.08
Viral Acute Myocarditis%WikiPathways_20191210%WP4298%Homo sapiens 6.44 4.87 2.76 9.89 -5.32 -6.49 -2.43 1.91 -2.7 -4.48 1.87 -1.64 -4.14 -4.47 -0.06 -0.24 1.89 6.75 -0.78 -1.26 6.65 2.14 -5.18 -5.87 -1.59 1.46
Disorders of Folate Metabolism and Transport%WikiPathways_20191210%WP4259%Homo sapiens -0.41 -0.11 3.45 5.46 -3.19 -2.54 0.68 0.44 0.09 -0.14 0.75 0.77 -1.04 -1.35 0.13 -0.91 0.73 1.76 -1.5 -1.4 2.65 0.3 -0.47 -1.7 -1.06 -1.38
Vitamin B12 Disorders%WikiPathways_20191210%WP4271%Homo sapiens 2.24 2.07 0.12 0.36 -0.8 -1.72 -0.82 0.34 -1.77 -0.79 -0.39 0.56 -2.3 -2.56 -0.23 -0.87 2.04 4.94 1.7 -1.09 2.89 0.27 -0.59 -0.93 -1.65 -1.03
Omega-9 FA synthesis%WikiPathways_20191210%WP4724%Homo sapiens -3.9 -2.33 -3.63 -4.77 2.01 0.84 0.63 0.38 1.91 2.45 -2.55 -0.04 2.82 2.56 -0.39 0.47 1.08 -1.61 -1.27 0.69 -2.06 -0.7 1.07 2.46 1.66 2.21
Mitochondrial complex I assembly model OXPHOS system%WikiPathways_20191210%WP4324%Homo sapiens 5.39 3.31 -9.72 -7.28 5.47 4.15 0.45 -3.04 0.09 1.12 -3.23 2.03 2.59 1.43 -3.33 -5.02 1.68 1.92 2.95 0.76 0.48 -2.07 0.59 -1.31 0.46 0.14
Sphingolipid Metabolism (integrated pathway)%WikiPathways_20191210%WP4726%Homo sapiens 2.11 2.15 0.08 1.74 -2.24 -1.71 -0.01 1.25 -2.96 -2.65 -0.15 -0.22 -2.8 -2.03 0.37 1.54 0.29 4.21 0.72 -0.41 4.2 3 -3.81 -3.87 -0.27 1.46
Overview of interferons-mediated signaling pathway%WikiPathways_20191210%WP4558%Homo sapiens 5.82 4.34 -0.31 1.74 -1.82 -3.38 -0.02 1.69 -1.01 -4.31 -1.14 0.84 -2.43 -3.03 -0.69 -0.83 2.26 6.52 1.83 -0.92 4.69 -0.47 -3.54 -3.6 -1.98 -0.25
Interactions between immune cells and microRNAs in tumor microenvironment%WikiPathways_20191210%WP4559%Homo sapiens -3.43 -2.37 -1 -3.63 2.83 3.44 0.97 1.06 1.54 1.72 -1.58 -0.09 2.6 3.3 1.85 1.38 -2.81 -6.08 1.86 0.93 -4.02 -1.33 2.77 3.5 -0.61 -2.8
22q11.2 Deletion Syndrome%WikiPathways_20191210%WP4657%Homo sapiens 0.95 -0.12 7.19 12.19 -3.46 -6.19 0.76 0.23 2.02 -1.58 5.57 -1.48 -1.86 -3.18 0.16 -0.98 1.54 0.87 -3.67 -3.24 3.26 1.75 -1.67 -4.93 -2.07 -2.05
Neural Crest Cell Migration in Cancer%WikiPathways_20191210%WP4565%Homo sapiens -2.66 -0.2 -3.39 -8.1 3.71 3.6 1.21 0.08 0.25 0.79 -2.26 0.67 2.68 2.89 -1.27 -0.16 -1.81 -1.95 2.87 2.8 -3.26 -1.88 1.6 4.51 0.26 -0.96
Omega-3/Omega-6 FA synthesis%WikiPathways_20191210%WP4723%Homo sapiens -0.73 -0.3 -4.71 -5.26 2.54 2.35 0.73 -0.26 0.84 2.41 -3.45 0.41 1.6 0.63 -0.57 -0.98 0.82 -0.28 0.07 1.35 -1.5 -0.65 0.37 0.69 1.68 2.19
Cysteine and methionine catabolism%WikiPathways_20191210%WP4504%Homo sapiens -4.27 -2.97 4.12 0.77 -1.53 0.28 1.62 -0.28 0.63 0.66 0.43 -0.72 1.38 0.63 0.06 1.55 -2.91 -2.88 -0.61 0.97 -1.78 -0.81 2.52 3.09 0.61 -0.56
Cell migration and invasion through p75NTR%WikiPathways_20191210%WP4561%Homo sapiens 4.9 3.73 0.18 2.72 1.85 0.54 -0.69 -1.74 0.53 0.26 2.16 0.76 -2.29 -2.39 -2.86 -2.73 1.58 2.08 2.11 0.59 -0.19 -1.9 -2.28 -3.52 -2.36 -1.04
Control of immune tolerance by vasoactive intestinal peptide%WikiPathways_20191210%WP4484%Homo sapiens -6.12 -4.34 0.63 -3.28 1.52 2.88 1.8 -0.49 0.67 1.88 -1 -1.25 3.08 3.22 1.75 -0.01 -1.59 -4.96 -2.05 0.35 -2.71 0.77 2.77 3.04 2.46 0.97
Relationship between inflammation, COX-2 and EGFR%WikiPathways_20191210%WP4483%Homo sapiens -3.42 -3.36 -1.37 -1.24 2.06 4.1 0.53 -1.89 1.52 1.21 -1.59 1.03 3.1 2.37 1.36 0.56 -2.72 -3.94 -1.02 1.39 -3.12 -1.54 3.48 4.04 0.33 -1.88
IL-10 Anti-inflammatory Signaling Pathway %WikiPathways_20191210%WP4495%Homo sapiens -1.55 -1.22 -4.19 -4.59 1.92 2.79 1.08 -0.34 1.64 2.59 -1.19 1.36 1.67 0.42 -0.52 -0.15 0.63 -1.72 -0.05 0.47 -1.5 -0.6 0.46 1.92 0.35 0.29
Selective expression of chemokine receptors during T-cell polarization%WikiPathways_20191210%WP4494%Homo sapiens -8.8 -7.17 0.67 -2.68 1.61 4.33 1.21 0.47 0.6 1.6 -1.4 -1.05 3.36 2.7 2.46 1.48 -2.12 -4.56 -1.98 1.37 -3.9 1.27 3.42 3.31 2.42 1.38
Neural Crest Cell Migration during Development%WikiPathways_20191210%WP4564%Homo sapiens -2.97 -0.32 -3 -7.85 3.13 3.35 1.02 0.03 -0.36 0.27 -2.42 0.55 2.56 3.05 -1.16 0.16 -1.8 -1.42 2.98 2.81 -2.77 -1.3 1.38 4.51 0.43 -0.87
FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma%WikiPathways_20191210%WP4553%Homo sapiens -0.77 -0.33 -1.74 -4.13 0.54 1.35 0.45 -0.65 1.8 1.19 -3.43 -0.84 1.59 2.78 1.5 -0.98 -0.71 -1.1 -1.88 1.17 -0.73 -0.56 2.13 3.34 1.26 -1.24
Hepatitis B infection%WikiPathways_20191210%WP4666%Homo sapiens -7.37 -6.52 -2.82 -6.64 4.19 6.8 2.6 -3.22 5.67 5.74 -1.81 0.25 5.65 6.21 1.77 0.78 -4.46 -7.62 1.16 1.82 -9.51 -3.68 7.02 7.56 1.06 -4.6
Bile Acids synthesis and enterohepatic circulation %WikiPathways_20191210%WP4389%Homo sapiens -4.75 -2.94 -0.36 -4.64 1.25 3.04 1.18 -0.16 0.83 1.55 -2.48 0.63 2 1.48 0.38 0.29 -0.19 -2.9 -0.77 0.14 -2.9 0.09 2.48 4.66 1.3 0.79
Signal transduction through IL1R%WikiPathways_20191210%WP4496%Homo sapiens 5.47 4.67 -0.36 -0.19 0.9 -2.65 -1.59 -1.09 -1.45 -1.92 1.58 -0.79 -1.5 -0.33 -3.78 -1.79 3.8 2.96 1.62 0.74 3.43 -0.88 -2.73 -4.36 0.24 0
Fragile X Syndrome %WikiPathways_20191210%WP4549%Homo sapiens 1.4 0.92 7.7 15.81 -5.69 -7.61 -3.23 1.06 -4.56 -3.63 4.19 -1.48 -4.24 -4.93 -0.72 -1.85 4.91 4.22 -4.17 -1.98 6.95 4.58 -4.39 -7.21 -0.43 4.38
Translation inhibitors in chronically activated PDGFRA cells%WikiPathways_20191210%WP4566%Homo sapiens -2.34 -2.7 2.49 5.34 1.35 2.02 0.94 -3.19 3.85 2.6 1.67 -0.3 0.36 2.17 0.68 1.65 -4.07 -3.47 0.22 -1.26 -6.16 -3.98 3.18 2.86 -0.54 -3.39
Nonalcoholic fatty liver disease%WikiPathways_20191210%WP4396%Homo sapiens 7.22 4.26 -14.29 -10.95 9.42 8.55 0.8 -5.19 2.5 3.02 -4.33 3.31 2.63 2.38 -2.9 -5.47 1.79 2.56 6.29 1.05 -3.25 -7.03 1.63 0.78 -1.41 -3.38
Platelet-mediated interactions with vascular and circulating cells%WikiPathways_20191210%WP4462%Homo sapiens -4.61 -3.86 -1.42 -2.66 0.65 2.97 1.08 0.84 1.39 2.46 -0.75 0.81 2.01 1.47 2.42 0.42 -0.31 -2.44 1.06 1.62 -3.74 -0.76 2.26 3.05 -1.54 -2.45
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement%WikiPathways_20191210%WP4560%Homo sapiens 0.22 0.3 -4.43 -6.77 2.31 3.56 -0.31 -1.08 0.76 0.49 -1.31 1.25 2 2.14 -1.09 -0.51 -1.92 -1.5 1.69 1.14 -1.53 -0.61 3.36 2.45 0.31 -0.93
Melanoma%WikiPathways_20191210%WP4685%Homo sapiens 1.1 1.43 5.42 7.57 -5.25 -6.01 -2.06 2.27 -5.03 -2.4 2.23 -2.06 -4.36 -3.35 0.2 1.14 2.46 3.71 -3.47 -2.1 6.31 5.06 -4.92 -5.01 2.17 4.95
Glycosylation and related congenital defects%WikiPathways_20191210%WP4521%Homo sapiens -1.58 -1.64 1.76 1.47 -1.78 -4.22 -1.79 0.24 -1.41 0.08 3.54 0.7 -1.13 -1.42 -0.8 2.66 1.87 1.98 -1.42 -3.21 3.01 2.65 -0.36 -1.66 0.13 2.32
Classical pathway of steroidogenesis, including diseases%WikiPathways_20191210%WP4523%Homo sapiens 2.45 2.12 -0.16 2.9 -1.48 -2.02 0.52 -0.94 -0.65 -0.73 2.41 -0.37 -0.86 -1.34 -0.97 -0.98 2.69 3.26 0.12 -1.53 2.15 -0.93 -1.82 -2.88 -1.17 0.21
Computational Model of Aerobic Glycolysis%WikiPathways_20191210%WP4629%Homo sapiens -1.31 -1.64 0.06 3 0.52 -1.09 -1.69 -0.96 0.11 -0.05 0.3 0.56 0.88 0.48 0.73 0.68 1.37 -2.14 -2.46 -1.53 1.1 3.19 -0.8 -2.5 0.88 2.33
Hippo-Yap signaling pathway%WikiPathways_20191210%WP4537%Homo sapiens 1.64 -0.02 4.52 8.53 -1.28 -1.08 -1.22 -1.1 0.2 -0.1 3.05 -1.74 -1.45 -0.66 -0.07 -0.91 -2.1 -0.87 0.34 -1.39 -0.1 -0.15 0.5 -2.63 -0.93 -0.99
Synaptic signaling pathways associated with autism spectrum disorder%WikiPathways_20191210%WP4539%Homo sapiens 0.31 0.19 3.73 5.96 -4 -4.59 -1.74 2.29 -3.13 -2.28 2.98 -1.24 -2.37 -3.55 0.67 -0.37 4.36 2.43 -4.11 -1.89 6.09 4.36 -3.33 -4.44 0.66 3.01
Hippo-Merlin Signaling Dysregulation%WikiPathways_20191210%WP4541%Homo sapiens 6.01 4.61 2.58 12.78 -3.98 -6.43 -2.64 0.29 -4.67 -3.44 5.57 -0.27 -5.28 -5.08 0.46 -1.29 3.54 5.74 -0.06 -2.83 4.68 2.39 -5.29 -8.79 -0.84 2.26
Regulatory circuits of the STAT3 signaling pathway%WikiPathways_20191210%WP4538%Homo sapiens 8.18 5.28 3 6.32 -3.73 -5.88 -1.69 0.48 -2.62 -3.17 3.58 -2.2 -4.17 -4.8 -0.29 -0.97 3.8 4.63 -0.92 -1.91 6.1 1.06 -4.98 -6.99 -0.45 2.37
Transcription co-factors SKI and SKIL protein partners%WikiPathways_20191210%WP4533%Homo sapiens 0.04 -0.93 6.24 4.32 -2.97 -2.5 -1.06 1.52 -1.03 -0.58 2.17 0.1 -2.43 -2.74 0.87 -0.77 0.53 -1.43 -1.98 -1.93 1.74 1.88 0.05 -2.52 1.75 1.69
Genes related to primary cilium development (based on CRISPR)%WikiPathways_20191210%WP4536%Homo sapiens -6.05 -4.39 12.38 10.66 -5.85 -3.09 -1.74 -0.17 -1.65 -0.03 5.03 -1.01 -3.01 -2.48 2.15 4.31 -2.68 -3.31 -3.63 -1.42 0.36 2.49 2.17 1.24 0.5 -0.77
Intraflagellar transport proteins binding to dynein%WikiPathways_20191210%WP4532%Homo sapiens -2.46 -2.09 6.32 4.81 -4.16 -2.87 0.27 0.5 -0.09 -0.28 3.03 -0.72 -1.45 -1.88 2.18 2.71 -0.4 -1.79 -2.99 -0.59 -0.48 1.77 1.24 -0.47 0.08 -0.19
Envelope proteins and their potential roles in EDMD physiopathology%WikiPathways_20191210%WP4535%Homo sapiens 5.22 2.68 3.13 7.29 -2.43 -2.49 -1.34 1.89 -3.75 -2.07 0.92 -1.67 -3.97 -3.94 -1.58 -0.65 1.89 1.38 -0.91 -1.9 4.16 3.06 -3 -3.9 -0.83 2.8
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms%WikiPathways_20191210%WP4534%Homo sapiens 5.34 4.09 -0.94 3.74 -1.28 -1.7 0.03 1.13 -3.65 -2.55 0.48 -0.35 -2.23 -1.11 -0.5 -1.98 2.25 5.29 1.41 -0.43 3.73 0.85 -5.99 -4.46 -1.31 0.16
Pathways Regulating Hippo Signaling%WikiPathways_20191210%WP4540%Homo sapiens 2.74 1.06 5 16.88 -4.49 -5.5 -2.81 -0.44 -3.73 -0.74 5.52 -0.1 -4.09 -5 0.3 -0.32 2.55 1.79 -2.07 -2.93 2.52 1.91 -3.38 -6.91 0.24 2
Small cell lung cancer%WikiPathways_20191210%WP4658%Homo sapiens 6.91 5.73 3.89 9 -4.26 -6.56 -0.21 0.83 -3.75 -4.24 2.45 -1.61 -5.3 -5.51 0.65 -0.53 2.65 5.7 -1.25 -3.59 6.73 1.57 -3.6 -6.6 -0.06 0.97
Joubert Syndrome%WikiPathways_20191210%WP4656%Homo sapiens -1.14 -1.39 10.2 11.2 -5.68 -4.86 0.02 0.57 -0.94 -1.34 3.64 -4.07 -2.57 -1.85 1 1.64 0.59 1.47 -2.98 -2.22 2.31 1.36 -1.99 -2.57 -0.4 0.03
Cytosolic DNA-sensing pathway%WikiPathways_20191210%WP4655%Homo sapiens 8.74 6.06 -1.49 0.7 0.04 -2.17 -0.98 -0.64 -2.21 -3.97 -0.49 0.58 -1.7 -2.43 -2.01 -1.84 5.22 7.12 2.15 -1.13 4.12 -0.48 -4.52 -6.16 -2.44 -0.07
Cancer immunotherapy by CTLA4 blockade%WikiPathways_20191210%WP4582%Homo sapiens -3.28 -2.02 -1.02 -1.11 1.39 2.47 0.4 -1.63 2.11 1.55 -1.03 0.43 2.14 2.96 1.34 0.28 -2.11 -5.03 -1.05 0.57 -3.09 -0.54 2.86 3.62 1.04 -1.26
Biomarkers for pyrimidine metabolism disorders%WikiPathways_20191210%WP4584%Homo sapiens -1.74 0.3 -0.82 -0.68 0.79 0.1 0.27 0.53 0.99 2.22 -1.06 0.42 0.45 -0.16 0.63 0.43 -1.58 -4.52 -0.8 0.24 -2.43 -0.46 1.93 3.43 0.8 0.72
Biomarkers for urea cycle disorders%WikiPathways_20191210%WP4583%Homo sapiens 0.01 2.37 -4.98 -3.33 1.92 2.76 0.13 0.37 0.48 1.31 -1.88 0.86 2.15 1.39 -0.17 0.57 -0.56 0.48 1.2 0.41 -1.36 -2.75 0.02 0.37 -1.11 -0.66
Cancer immunotherapy by PD-1 blockade%WikiPathways_20191210%WP4585%Homo sapiens -3.25 -3.66 -2.13 -5.19 2.96 3.51 -0.9 -1.81 0.44 2.08 -2.19 0.9 3.37 2.48 0.45 0.83 -0.18 -3.8 -0.16 -1.14 -3.2 0.94 3.05 3.65 1.76 1.2
Pathways of nucleic acid metabolism and innate immune sensing%WikiPathways_20191210%WP4705%Homo sapiens -1.17 -1.83 3.93 7.31 -1.57 -1.83 0.7 0.1 -0.06 -0.49 0.64 0.33 -2.32 -1.96 0.45 -0.99 -0.12 -1.43 -1.61 0.53 1.86 0.98 0.33 0.36 -0.97 -1.19
Major receptors targeted by epinephrine and norepinephrine%WikiPathways_20191210%WP4589%Homo sapiens 4.62 1.62 1.58 6.36 0.93 0.33 -1.08 -0.9 -1.33 -0.69 2.14 -0.17 -2.13 -3.24 -2.02 -1.93 1.97 0.35 -1.11 -2.59 0.59 0.52 -0.36 -3.33 -0.68 0.56
Urea cycle and associated pathways%WikiPathways_20191210%WP4595%Homo sapiens 3.54 3.8 -2.96 0.25 -0.24 -1.8 -0.99 -1.08 -0.95 -2.19 0.34 0.36 -0.99 -1.19 -2.05 -2.26 3.89 4.62 1.28 -0.13 2.86 0.76 -2.18 -2.09 -0.42 -0.19
Eicosanoid metabolism via Cyclo Oxygenases (COX)%WikiPathways_20191210%WP4719%Homo sapiens 5.1 2.18 2.47 1.67 -1.27 -4.44 -2.06 0.39 -2.72 -2.42 2.09 0.1 -2.61 -1.47 -1.1 -0.31 1.57 3.55 1.87 -0.78 3.58 2.1 -3.23 -3.3 -0.93 -0.02
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways)%WikiPathways_20191210%WP4718%Homo sapiens 5.73 2.75 4.03 7.9 -2.96 -3.06 -2.8 -1.86 -2.65 -3.42 4.9 -1.05 -2.17 -2.17 0.01 -0.63 0.96 4.2 0.87 -1.44 2.78 1.92 -2.54 -5.11 -2.39 -1.79
Genes involved in male infertility%WikiPathways_20191210%WP4673%Homo sapiens 9.56 7.81 3.81 8.71 -6.1 -9.18 -2.03 1.69 -3.65 -5.5 4.44 0.9 -6.97 -6.4 -1.54 -1.8 6.1 8.36 1.34 -1.8 9.56 0.44 -7.12 -8.44 -3.02 0.84
Head and Neck Squamous Cell Carcinoma%WikiPathways_20191210%WP4674%Homo sapiens 2.27 1.21 7.27 11.39 -4.13 -5.06 -0.65 -0.04 -1.32 -1.49 4.64 -1.19 -3.62 -3.82 -0.13 0.14 1.41 1.33 -3.66 -2.61 4.17 1.54 -2.62 -5.08 -0.46 0.54
Eicosanoid metabolism via Lipo Oxygenases (LOX)%WikiPathways_20191210%WP4721%Homo sapiens -2.13 -1.12 -0.76 -1.15 4.02 5.09 0.98 -0.84 2 1.49 -1.09 -1.79 2.15 2.47 0.34 -0.95 -2.37 -3.38 1.01 0.8 -6.29 -1.9 3.18 1.41 0.13 -1.32
Sphingolipid Metabolism (general overview)%WikiPathways_20191210%WP4725%Homo sapiens 2.11 2.15 0.08 1.74 -2.24 -1.71 -0.01 1.25 -2.96 -2.65 -0.15 -0.22 -2.8 -2.03 0.37 1.54 0.29 4.21 0.72 -0.41 4.2 3 -3.81 -3.87 -0.27 1.46
Nephrotic syndrome%WikiPathways_20191210%WP4758%Homo sapiens -5.01 -4.04 -1.48 -5.45 0.88 3.38 0.42 0.42 1.43 2.91 -2.13 0.87 3.81 3.48 0.08 0.39 -3.48 -6.84 -0.9 1.95 -2.97 0.48 3.75 5.04 2.09 0.9
Gastrin Signaling Pathway%WikiPathways_20191210%WP4659%Homo sapiens -4.94 -3.53 -6.48 -13.02 6.92 7.18 1.6 -0.28 4.31 3.18 -4.85 1.28 4.7 5.22 0.66 -0.05 -1.79 -4.79 1.37 2.57 -5.99 -3.35 4.17 6.62 1.23 -1.92
